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ABSTRACT 
PETRA MICHELLE SANDER: Alcohol and HIV Seroconversion in Men Who Have Sex 
with Men 
(Under the direction of Stephen R. Cole) 
Previous findings linking alcohol consumption and HIV seroconversion among men 
who have sex with men (MSM) have been inconsistent. This study argues those findings may 
be limited by inadequate control for confounding due to time-updated factors affected by 
prior alcohol consumption. We examined prospective data from 3,725 HIV-seronegative 
MSM enrolled in the Multicenter AIDS Cohort Study (MACS). Participants made 
semiannual study visits from 1984-2007, self-reported alcohol consumption, and underwent 
HIV testing. Potential predictors of alcohol consumption were explored. Demographic and 
time-updated factors including smoking, self-reported depression symptoms, illicit drug use 
and sexual practices were considered. Associations were modeled using logistic and 
lognormal multivariable regression. We next examined the joint effects of alcohol 
consumption and unprotected receptive anal intercourse (URAI) on HIV seroconversion. At 
baseline, median alcohol consumption by seronegative MACS men was 5 drinks/week 
(interquartile range (IQR): 1-12) and 18% were nondrinkers. Over 47,261 follow-up visits, 
median alcohol consumption was 2 drinks/week (IQR: 0-8) and 26% of participants were 
nondrinkers. Comparing users of marijuana, poppers and cocaine to non-users, the odds ratio 
(OR) for any current drinking among drinkers at the prior visit was 2.90 (95% CL: 2.21, 
3.80). For this group, the median number of drinks consumed per week was 1.14 (95% CL: 
1.11, 1.18) times the median consumed by non-users. Over follow-up, 529 HIV 
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seroconversions occurred. After accounting for several measured confounders using a joint 
marginal structural Cox proportional model, the hazard ratio (HR) of HIV seroconversion for 
moderate drinking (1-14 drinks/week) compared to nondrinking was 1.10 (95% CL: 0.78, 
1.54) and for heavy drinking (>14 drinks/week) was 1.61 (95% CL: 1.12, 2.29) compared to 
nondrinking. The HRs for heavy drinking compared to nondrinking for participants with 0-1 
or >1 URAI partner were 1.37 (95% CL: 0.88, 2.16) and 1.96 (95% CL: 1.03, 3.72), 
respectively (robust joint Wald P for interaction = 0.42). These findings suggest first, that 
illicit drug use may identify MSM whose alcohol puts them at risk for adverse alcohol-
related health outcomes, and second, that alcohol interventions to reduce heavy drinking 
among MSM should be integrated into existing HIV prevention activities. 
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CHAPTER I 
SPECIFIC AIMS 
Introduction 
Alcohol consumption is believed to be an upstream determinant of drug use and 
sexual risk behavior and therefore an indirect determinant of human immunodeficiency virus 
(HIV) risk; however, little empirical evidence exists to support the latter claim and the 
possible (immune-modulated) direct effects of alcohol on HIV have not been considered. 
Findings related to alcohol exposure have been inconsistent [1-14] and therefore insufficient 
to support increased HIV prevention activities targeted at drinking behavior. The overall goal 
of this study is to estimate the impact of alcohol consumption on HIV acquisition using 
quantitative methods that permit the unbiased estimation of causal effects under stated 
assumptions. 
The aims have been undertaken with data from the Multicenter AIDS Cohort Study 
(MACS), which is based in four United States (US) metropolitan areas: Baltimore, 
Maryland/Washington, DC; Pittsburgh, Pennsylvania; Chicago, Illinois; and Los Angeles, 
California. Since 1984, this cohort of men who have sex with men (MSM), has collected data 
on 3,725 men at risk of contracting HIV, of whom 562 had seroconverted by 1 January 2008. 
MACS participants are monitored through semiannual study visits, at which they provide 
blood samples for HIV testing and repository and complete interviewer-administered and 
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computer-assisted interviews concerning demographic, medical and behavioral data. This 
observational cohort represents perhaps the best available domestic data source to consider 
long-term alcohol consumption, which is impossible to assess using a randomized design. 
An unbiased and precise estimate of the effect of alcohol consumption on HIV 
seroconversion is essential to the development of targeted HIV interventions for men who 
have sex with men and other groups at risk for HIV in which alcohol consumption is 
common.  
Specific aim 1. Estimate the association of measured behavioral and demographic factors 
with subsequent alcohol consumption. 
Hypothesis 1: Baseline demographic factors (e.g., younger age, white race, non-
Hispanic ethnicity), prior time-varying high risk health behaviors (e.g., higher number 
of past sexual partners, higher number of acts of unprotected receptive anal 
intercourse, illicit drug use), and prior time-varying biomedical factors (e.g., serious 
health concerns in the medical history, body-mass index, weakened immune function) 
will be associated with heavier subsequent alcohol consumption. 
Specific aim 2. Estimate the effect of alcohol consumption on the risk of HIV 
seroconversion. 
Hypothesis 2.1: High levels of alcohol consumption will be related to an increased 
risk of HIV seroconversion independent of prior behavioral and demographic factors. 
We will observe a threshold effect wherein the highest quartile of drinkers shows an 
increased risk of HIV seroconversion when compared to the lowest three quartiles of 
drinkers.  
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Hypothesis 2.2: Alcohol consumption within the 12 months prior to HIV 
seroconversion will show a stronger association with HIV seroconversion than 
alcohol consumption in the 36 months prior to HIV seroconversion.  
Hypothesis 2.3: The joint effects of high levels of alcohol consumption and multiple 
unprotected receptive anal intercourse partners will be greater than those expected 
under multiplicative combination. 
 
 
 
CHAPTER II 
BACKGROUND AND SIGNIFICANCE 
The HIV epidemic among MSM in the US 
According to 2006 estimates there were 56,300 [15] new HIV infections in the US 
with MSM transmission accounting for 72% of male seroconverters including 81% of new 
infections among whites, 63% among Blacks, and 72% among Hispanics [16]. Among MSM, 
unprotected anal intercourse, particularly unprotected receptive anal intercourse, is the major 
mode of HIV transmission [17-25] with an estimated per contact infectivity of 0.82% (95% 
CL: 0. 24, 2.76) [17]. The friction of anal-penile sexual contact is thought to compromise 
innate immunity at the mucosal surface by producing micro-tears in the epithelial linings of 
the rectum and colon, allowing cell-free HIV to be transcytosed into the underlying lamina 
propria. There it may locally infect HIV target cells, including submucosal dendritic cells, 
Langerhans cells and CD4+ T cells before ultimately spread via the lymph nodes and 
producing systemic infection [26, 27].  
In the absence of an HIV vaccine to protect high-risk populations, behavioral 
interventions to modify high-risk behaviors or their prerequisites are primary intervention 
strategies [28]. Problem alcohol use is common among MSM at risk for HIV [29] and a 
frequent co-diagnosis among those who test positive for HIV or are receiving treatment [30]. 
Therefore, substance abuse in general and alcohol abuse in particular are gaining attention in 
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the field of HIV treatment adherence research [31, 32], particularly as these activities may 
lead to physiologic changes that lead to poor prognosis [33] and hasten progression to AIDS 
[34].  
Alcohol consumption in the US 
Two-thirds of the US adult population identify as alcohol consumers [35], making 
alcohol along with caffeine and nicotine, one of the most widely used addictive substances 
nationally. Moderate to heavy drinkers make up 20% of the drinking population (Figure 2.1), 
with a smaller proportion of the population reporting heavy (>14 drinks/week for men) or 
binge (>5 drinks per sitting for men) than in Europe [36]. Among adult males in the general 
population, alcohol use (i.e., choosing to drink alcohol rather than abstaining) is associated 
with white race, higher levels of education, younger ages, and being married. Higher levels 
of alcohol consumption, the number of drinks consumed in a typical day, among those who 
drink are associated with more recent birth cohort, younger age, periods of higher per capita 
drinking, being unmarried, non-white race, higher levels of education, non-suburban 
residence, smoking, and psychological comorbidities, particularly depression [37, 38]. 
MSM were historically thought to consume alcohol at rates that exceed the general 
population. As reviewed extensively by others [39, 40], early studies of alcohol consumption 
and alcohol-related disorders among MSM observed low abstention rates, high alcohol 
consumption and smaller age-related declines in alcohol consumption when compared to the 
general population [41, 42]. However, these studies suffered from bias due to recruitment of 
homosexuals from alcohol-saturated settings (e.g., gay bars, urban settings) and differential 
recruitment of MSM and general population participants. Early findings were not 
corroborated by population-based studies of alcohol consumption that employed random-
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digit dialing of homosexuals and heterosexuals [40, 43]. Additionally, knowledge of the 
ongoing HIV epidemic among MSM has corresponded to overall declines in alcohol abuse 
[44]. 
 
Literature review 
Three types of studies characterize the existing literature linking alcohol consumption 
to HIV and sexual risk behavior: general association studies, which consider average 
measures of alcohol consumption and resulting outcomes; situational covariation studies that 
consider the use of alcohol in specific (e.g., sexual) contexts; and event-level analyses that 
consider risk behavior around the time of an index sexual act [45-50]. When HIV infection is 
the outcome, the latter study types are subject to differential recall bias, because the precise 
timing of infection is usually unknown to the study participant and he may preferentially 
assign the index act to a time at which he engaged in high risk activities. By contrast, 
seroconversion, the development of an antibody response by the immune system to HIV, can 
be detected independent of the participant self-report and is more frequently the outcome in 
general association studies.  
A review of twenty African studies of alcohol consumption which focused primarily 
on heterosexual HIV transmission and included three prospective studies, reported an 
unadjusted pooled odds ratio of 1.70 (95% CL: 1.42, 1.72). While the drinking status of HIV-
positive individuals is certainly of interest to the study of predictors of care seeking and 
treatment adherence, cross-sectional associations are insufficient to support causal 
conclusions linking alcohol consumption to HIV seroconversion. There is no assurance that 
alcohol consumption prior to HIV seroconversion resembles use after diagnosis at the time of 
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interview, indeed high risk behaviors are likely to change following notification [51]. 
Therefore, subsequent discussion will be limited to studies that gather information on alcohol 
consumption or use during at least one period prior to HIV diagnosis. This approach assures 
the temporal order role of alcohol consumption vis-à-vis HIV seroconversion.  
To our knowledge, 14 previous studies [1-14] have considered alcohol use 
prospectively with HIV seroconversion as an outcome in a variety of populations (Table 
2.1). These studies report relative unadjusted effect measures between 1.21 (comparing light 
to nondrinkers [11]) and 4.82 (comparing individuals drinking more than 30 standard 
alcoholic drinks per week to nondrinkers [10]). Adjustment for a variety of baseline 
covariates including: sociodemiographic factors such as race [2, 5, 9, 11], ethnicity [9, 11], 
religion [4, 6], age [1, 4-6, 9, 10], and education level [2, 5, 6, 9]; and variables considered to 
be time-dependent confounders or intermediates including: illicit drug use [2, 3, 5, 9, 11, 13] 
or injections [10], number of sexual partners [4, 6, 9, 11, 12], mental health [2, 9, 11], 
immunological health [2], risky sexual behavior [1, 3, 6, 9, 10, 13, 14] and history of other 
sexually transmitted infections [4, 10, 11, 13] attenuates the relationship been alcohol 
consumption and HIV seroconversion substantially at all but the most extreme levels of 
consumption. An inverse-variance-weighted estimate of the eight studies that provide 
adjusted results and sufficient details on confidence limits [2, 4-6, 9-14], gives an average 
effect of 1.57 (95% CL: 1.45, 1.69). However, this measure is likely biased away from the 
null due to the exclusion of negative studies that do not report sufficient data for averaging 
[1, 3, 7]. When we attempt to recapture the influence of these studies by assuming their 
standard error is a function of the number of observed events and that these events were 
distributed equally across the exposure levels, the average effect is 1.42 (95% CL: 1.32, 
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1.53). Thus, the previous studies on this subject collectively support an association between 
alcohol consumption HIV risk; however, the causal link between alcohol and HIV 
acquisition is an open question due in part to shortcomings as well as the differences 
observed between studies [52].  
At the time this research was proposed no previous study that included time-varying 
exposure or covariate levels has appropriately estimated the effect of alcohol on HIV 
seroconversion as there is confounding by time-dependent covariates (e.g., sexual risk 
behaviors, immunological health, drug use, etc.), which are determined in part by prior 
alcohol consumption and both predict HIV seroconversion and subsequent alcohol 
consumption (Figure 2.2) [53]. Under these conditions traditional adjustment approaches 
(e.g., regression methods), even those which adjust for time-dependent confounders, may 
produce biased estimates of the effect estimate of interest [54]. Therefore, the opportunity 
exists to apply novel techniques [54], which allow for the unbiased estimation of time-
dependent alcohol consumption on HIV seroconversion, adjusting for both baseline and time-
dependent confounding. 
 
Measurements of alcohol consumption in the HIV seroconversion literature  
Self-report of alcohol consumption is notoriously unreliable [55-59] and is highly 
dependent on the context in which it is reported. When excessive alcohol consumption is 
socially undesirable or suggestive of pathology it may be underreported by participants; 
when it gives the appearance of being more worldly or when the drinkers have previously 
self-identified as heavy alcohol consumers, it may be over-reported [59]. The failure of 
participants to respond truthfully as has been seen in epidemiologic and substance abuse 
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literature [58] is also apparent in studies of alcohol consumption and HIV acquisition. Here, 
Woolf and Maisto warn that “Continuing to take a unitary approach to research design could 
impede the advancement of knowledge regarding alcohol use and risky sex among MSM. 
Unfortunately it appears that researchers in this area have done little to obtain empirical 
evidence on the reliability or accuracy of the self-report data that they do collect” [60]. 
In the previously cited meta-analyses of alcohol consumption and HIV infection [46, 
60], the authors have considered alcohol use as a dichotomous (yes or no) variable, 
regardless of the time period covered or if the study queried using a diagnostic instrument 
such as the Alcohol Use Disorders Identification Test (AUDIT) or its abridged form, the 
AUDIT-C (Table 2.2), another quantity-frequency questionnaire, or a contextual marker of 
alcohol consumption, such as living in a home from which alcohol is sold. Similarly, alcohol 
consumption measurement in prospective studies has relied exclusively on non-validated 
self-report, and has generally been dichotomized by the authors into categories of ever vs. 
never or heavy drinker vs. non-heavy drinker using various cut points (Table 2.1). Only the 
study by Watson-Jones et al. presents adjusted and unadjusted effect measure estimates 
across exposure levels of alcohol, reporting adjusted hazards ratios of HIV seroconversion of 
1.73, 3.00 and 4.39 for drinking levels of 1-9, 10-29 and ≥30 drinks per week reported at a 
baseline screening interview relative to nondrinkers [10]. However, even this exposure 
metric is not indicative of consumption history as it relies on a single self-report drinking 
obtained at baseline. Alcohol exposure is dynamic, with variation due to day of the week, age 
and even employment status [61], therefore a more appropriate metric would consider how 
duration, frequency and intensity of alcohol use as it changes over time. The measures used 
by Kippax et al. [1] and Zablotska et al. [6] define the timing of alcohol use with respect to 
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sexual contact and reflect an “event level” analytic approach. In the study by Kippax et al. 
[1], respondents report on the sex act at which they believe they were infected with HIV, a 
possibly misleading approach due to differential recall. Zablotska et al. [6] consider alcohol 
consumption by one or both partners as a risk factor; however, the reported findings do not 
distinguish which partner was drinking. The drinking status of the HIV negative partner may 
influence the risk of HIV transmission through behavioral and immunological pathways; 
Zablotska et al.’s approach, however, would muddy the indirect effects due to biological 
changes.  
Biomarkers have been applied to assess the validity of self-reported alcohol 
consumption by insurance agencies [62], in dependence research [63] and law enforcement, 
all settings where confidence in accurate self-report is low. No gold standard for measuring 
moderate to long term alcohol intake exists across all levels of consumption, however 
personal monitoring of the transdermal or exhaled ethanol to measure a Blood Alcohol 
Content (BAC) around the time alcohol is imbibed (within 8 hours) is likely the best measure 
currently available of acute drinking [64]. Both these methods are used, for example, when 
legal or health concerns warrant heightened vigilance [65]. However, they are costly, 
intrusive, and measure only short-term consumption. 
 
Alcohol and sexual risk behavior 
The acute influence of alcohol consumption on human behavior is biphasic [66]. 
Beginning soon after drinking onset, at a BAC of 0.02-0.05 g/dL, the response to alcohol is 
stimulatory and includes the experience of mild euphoria and a reduction in anxiety. As the 
number of drinks imbibed increases, alcohol acts as a depressant: at BAC levels of 0.06-0.10 
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(3-5 drinks), judgment and motor coordination are impaired; at a BAC of 0.20-0.25 (~10 
drinks) there are signs of sedation; and at higher levels, loss of consciousness, asphyxiation, 
coma and death are more likely [67, 68]. Alcohol levels of as low as 0.1 may interfere with 
maintaining an erection [68]; however, the precise impact of alcohol on sexual function is 
highly dependent on context [69]. The median lethal dose of ethanol corresponds to a BAC 
of approximately 0.4-0.5 [67]. 
In popular opinion, alcohol consumption is a social lubricant associated with an 
attitude of disinhibition and risk taking, particularly sexual risk taking [70]. This intuitive 
understanding is borne out by some [71-78], but not all [79-83] epidemiologic investigations 
of the subject among MSM. Alcohol consumption was associated with higher numbers of 
sexual partners [84, 85], higher numbers of unprotected anal sex acts, and condom failure 
[86]. The influence of alcohol was modified by partner type [72, 87, 88] and sexual behavior 
[74, 89] with casual partners and receptive anal intercourse with individual of unknown HIV 
status correlating to alcohol consumption prior to sex.  
Behavioral scientists have studied this association and posited three theoretical 
models [23, 90] through which to understand increased individual sexual risk behavior 
following alcohol use.  
Alcoholic myopia, or the ability of alcohol to cloud short-term decision making 
processes, may predict sexual risk behavior [91]. Specifically, alcohol limits the attention 
capacity of the intoxicated person and causes them to overlook both internal and external 
inhibiting cues (e.g., a prior knowledge that unprotected sex is risky, no available condom). 
In laboratory settings, young men who were sexually aroused were more likely to report the 
intention of having unprotected sex if they were intoxicated than if they were sober [92]. Yet 
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several population-based cross-sectional studies [81, 93] and an event-level analysis [94] 
failed to show reduction in condom use when alcohol consumption preceded sex. Indeed, the 
results suggest that pre-existing behavior patterns were unaltered by drinking [94], and that 
observed unsafe sex practices under the influence were common to participants who were 
also inconsistent condom users while sober.  
Alcohol expectancy theory posits that individuals drink in anticipation of a heightened 
sexual experience [95]. This is supported by research in adolescents that shows alcohol use is 
associated with earlier initiation of sexual activity and more sexual partners [96-98]. Among 
MSM, the consumption of alcohol accompanies a desire to cognitively escape from fears of 
HIV risk [99, 100]. 
A third behavioral theory suggests that risky sexual behavior and alcohol use may 
both be expressions of an underlying risk-prone personality type [23, 94, 101]. The presence 
of a sensation-seeking personality type assessed through survey inquiry into dimensions of 
thrill and adventure-seeking, experience-seeking, disinhibition, and susceptibility to boredom 
[102]. Zuckerman [102] found that individuals who scored high on a questionnaire assessing 
sensation-seeking had more sexual partners compared to participants who scored low. 
Sensation-seeking is also implicated in initiation and addiction to illicit substances and is 
believed to wane with increasing age [103]. Kalichman and his colleagues have conducted 
numerous studies of sensation-seeking in relation to alcohol consumption and sexual risk 
behavior, concluding that risk-prone personality types are influential in both behaviors [98, 
104-106].  
13 
 
Physiologic responses to alcohol 
A healthy occasional drinker can metabolize one standard drink (Table 2.3) in one 
hour. When a person ingests an alcoholic beverage, the ethanol it contains passes into the 
stomach and intestinal tract, where it may be immediately metabolized by alcohol 
dehydrogenase (ADH) isoenzymes. The extent of this first pass metabolism is influenced by 
the amount of time alcohol remains in the stomach. Unmetabolized ethanol passes from the 
stomach and intestines into the circulatory system and on to the liver for metabolism. There, 
ethanol is converted into acetaldehyde by ADH and then from acetaldehyde into acetic acid 
by aldehyde dehyrodgenase (ALDH). Depending on the needs of the body, acetic acid is 
further metabolized into carbon dioxide and water or transported to cells outside of the liver. 
Oxidized nicotinamide adenine dinucleotide molecules act as coenzymes required for the 
activity of both alcohol metabolizing enzymes. Once reduced, this coenzyme may shuttle the 
energy from the breakdown of alcohol to other parts of the cell.  
Polymorphic variants of the genes that encode alcohol metabolism enzymes are 
associated with altered kinetic properties. These have been linked to differences in alcohol 
consumption patterns and may explain some of the disparities observed in alcohol 
dependence across races and ethnicities [107, 108]. For example, homozygosity for the 
ALDH2*2 allele is associated with low-dose alcohol hypersensitivity (e.g., flushing and 
general discomfort) and with a reduced likelihood of heavy drinking and alcoholism in 
Asians [109, 110]. Similarly ADH variants ADH1B*2 and ADH1B*3, most common among 
those of Asian and African descent, also appear to confer a greater sensitivity to alcohol 
consumption [111, 112]. 
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Alcohol consumption has consequences for virtually every part of the body, including 
the immune system. For example, it is well established that chronic alcohol consumption is 
associated with increased susceptibility to bacterial infection, including tuberculosis [113]. 
No confirmed biologic mechanism has been established linking acute or chronic alcohol 
consumption to HIV infection. Nevertheless, two general hypotheses are currently under 
exploration in the laboratory: first, that alcohol increases host cell susceptibility to initial HIV 
infection and second, that once cells are infected, HIV proliferation is enhanced in the 
presence of alcohol and may hasten an individual’s progression to AIDS [101]. 
A study in humans collected peripheral blood monocytes (PBMCs) from six healthy 
adult volunteers before and after a weekend of social drinking (700 to 3100 ml of beer or an 
equivalent amount of alcohol in another beverage) and measured the ability of HIV-1 to 
replicate in the PBMC in vitro [114]. Alcohol consumption was correlated with an increase 
in HIV-1 replication in the PBMCs and a decreased ability of these cells to produce 
cytokines, such as interleukin-2 (IL-2), which regulate the responses of other immune 
components to the virus-infected cell. A second study applied the same hypothesis as above, 
this time with 60 healthy volunteers who were asked to engage in “social drinking” over a 
weekend. In this case, moderate alcohol consumption (53.50g alcohol ± 15.00) greatly 
increased HIV replication in PBMCs and was associated with decreases in both T-helper and 
T-suppressor cell function. A reduction in CD8+ T cells in turn leads to an increase in HIV 
replication in vitro [115]. 
Alcohol acts directly on HIV target cells. Exposure of human and mouse T cells to 
alcohol treated dendritic cells led to T cell anergy and impaired proliferation to subsequent 
stimulation [116, 117]. In the oral cavity, alcohol-exposure increased cell-surface expression 
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of the CXCR4 receptor [118]. Secondary effects of alcohol exposure include modulation of 
cytokines released from immune cells: dendritic cell function appears to decline in response 
to alcohol exposure, leading to a decrease in IL-12 circulation and an increase in IL-10 [119]. 
Under binge drinking conditions, an increase in pro-inflammatory cytokines was observed 
[120] alongside an increase in the proportion of HIV-susceptible cells in the circulatory 
system [121]. Chronic alcohol consumption reduces delayed-type hypersensitivity response 
[122, 123], decreases the absolute lymphocyte count, reduces macrophage functions [116, 
124], increases natural killer cell activity, and increases tumor necrosis factor production 
which may in turn increase HIV-1 replication. Among immunized macaques, exposure to 
simian immune deficiency virus was associated with a hastened SIV-related decrease in 
CD4+ T cells in alcohol-consuming versus control animals [125].  
 
Significance 
Our study of alcohol consumption in the nation’s largest cohort of MSM at risk for 
HIV infection addresses deficiencies in the current literature and aims to improve upon 
existing methodological approaches for handling confounding. Our work specifically builds 
on the contributions of Penkower, et al. [2] who were to our knowledge the first to 
investigate alcohol and HIV seroconversion with prospective data drawn from the early 
waves of MACS. The inability of the field to reach consensus since 1991 speaks to the 
necessity of this research. 
Alcohol dependency is a behavior that often requires intense intervention to realize 
long-lasting behavior change. Pre-treatment and post-treatment comparisons of heterosexuals 
receiving individualized alcohol treatment showed decreased HIV risk behaviors, including 
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unprotected intercourse, a year after entry into alcohol treatment; however, the numbers of 
observed seroconversions was too small to draw conclusions about that endpoint [126]. 
Compared to their peers, MSM may be less likely to seek individual treatment for alcohol use 
disorders [127] and if they do enter, may leave due to limited MSM-specific training of 
treatment providers or overt homophobia [128]. Community-based HIV prevention 
interventions targeted specifically at MSM that include modules about negotiating 
intercourse under the influence of alcohol but do not directly promote reduced consumption 
of alcohol have been tested [129, 130]. However, the long-term impact of these interventions 
is unclear. Community-based interventions in South Africa based on the World Health 
Organizations’ model of alcohol intervention, which includes motivational and behavioral 
skills training, have been associated with promising short-term declines in risky sexual 
practices [131, 132].  
A first step in this effort to design appropriate alcohol interventions for MSM in the 
US is to provide convincing findings using the most rigorous analytic approaches available to 
present to policymakers and primary care providers who remain unconvinced that alcohol 
intervention is an HIV prevention activity.  
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Table 2.1. Prospective studies of alcohol and HIV seroconversion. 
 
First Author, Year, and 
Reference Location Exposure Metric 
Exposure 
Assessment 
Timing/Frequency 
HIV 
seroconversions 
(Study 
Population) 
Unadjusted 
Estimate 
(95% CL) 
Adjusted 
Estimate 
(95% CL) 
                            
Penkower, 1991 [2]a Pittsburgh, Los 
Angeles, Baltimore, 
Chicago 
At least weekly 
drinking of 3 -4 
drinks 
Baseline 181 (644) 2.28 (1.55, 3.36) 1.39 (1.12, 1.72) 
Celentano, 1996 [13] Northern Thailand Use/nonuse for the previous 6 months 
Baseline + 
semiannually 85 (1932) 2.92 (1.05, 8.08) 1.72 (0.61, 4.85) 
Page-Shafer, 1997 [12]a Amsterdam, the 
Netherlands; San 
Francisco; Vancouver, 
Canada; Sydney, 
Australia 
Use/nonuse for the 
6-month interval 
before the visit 
Once (Pre-
seroconversion 
period ) 
345 (690) 1.67 (0.88, 3.16) 1.73 (0.90, 3.45) 
Chesney, 1998 [3]a 
San Francisco 
5+ drinks at a time 
on at least a weekly 
basis 
Baseline+ 
semiannually 39 (337) 2.74 (1.26, 5.92) NS 
Kippax, 1998 [1]a Sydney, Australia 5-point Likert-like alcohol usage scale Baseline 23 (392) NS NS 
Kapiga, 1998 [4] Dar es Salaam, 
Tanzania 
Any drinking during 
follow-up period 
Baseline + 
semiannually 75 (2471) 2.43 (1.54, 3.82) 1.85 (1.14, 3.00) 
Nopkesorn, 1998 [14] Northern Thailand 8+ drinks at a time Baseline + month 6, 17 and 23 14 (1036) 3.8 (1.1, 12.8) 3.1 (1.0, 10.9) 
Wang, 2005 [5] Baltimore Daily alcohol use Baseline + semiannually 308 (1927) -- 1.15 (0.82, 1.62) 
Zablotska, 2006 [6] 
Rakai, Uganda 
Both partners drank 
before most recent 
sexual encounter 
Baseline + every 
10-12 months 287 (14875) 2.12 (1.60, 2.81) 
1.58 (1.13, 2.21) 
 
Mehta, 2006 [7] Baltimore Not defined Baseline + semiannually 304 (1984) Significant NS 
Koblin, 2006 [11]a 
Boston, Chicago, 
Denver, New York, 
San Francisco, Seattle 
Light (≤3 drinks/day 
on no more than 1–2 
days/week), 
Moderate (4-5 
drinks/day on no 
Baseline + 
semiannually 259 (4295) 
Light vs. None 
1.21( 0.79, 1.87) 
Moderate vs. None 
1.45 (0.92, 2.28) 
Heavy vs. None 
Heavy vs. 
<Heavy 
1.97 (1.32, 2.96) 
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First Author, Year, and 
Reference Location Exposure Metric 
Exposure 
Assessment 
Timing/Frequency 
HIV 
seroconversions 
(Study 
Population) 
Unadjusted 
Estimate 
(95% CL) 
Adjusted 
Estimate 
(95% CL) 
more than 
1–2 days/week, or 1-
5 drinks/day on 3–6 
days/ 
week, or 1-3 
drinks/day on a daily 
basis) 
Heavy ( ≥4 drinks 
every day or ≥6 
drinks on a typical 
drinking day) 
2.75 (1.62, 4.66) 
Read, 2007  [8]a 
Victoria, Australia 
Alcohol use (>60 
g/sitting) at least 
weekly in the year 
before test 
At time of test 26 (644) 3.6 (1.1, 11.4)  ---- 
Plankey, 2007 [9]a Baltimore-
Washington, DC; 
Chicago; Los Angeles; 
and Pittsburgh 
Binge: 5 + drinks 
per occasion at least 
monthly. 
Baseline + 
semiannually 436 (4003) 2.05 (1.53 , 2.74) 1.13 (0.81 , 1.56) 
Watson-Jones, 2008 
[10] 
Northwestern Tanzania 
Number of drinks 
per week reported at 
baseline 
Baseline 63 (821) 
1-9 vs. 0 
1.85 (0.99, 3.46) 
10-29 vs. 0 
3.41 (1.76, 6.62) 
≥30 vs. 0 
4.82 (1.91, 12.13) 
1-9 vs. 0 
1.73 (0.92, 3.27) 
10-29 vs. 0 
3.00 (1.51, 5.98) 
≥30 vs. 0 
4.39 (1.70,11.33) 
 
Abbreviations: CL, confidence limit; NS, not significant. 
aThis study was restricted to men who have sex with men 
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Table 2.2. The Alcohol Use Disorders Identification Test – Consumption questions [133]. 
For men, a score >4 is considered positive (i.e., optimal for identifying hazardous drinking or 
active alcohol use disorders).  
 
1. How often do you have a drink containing alcohol?    SCORE 
Never (0)  
Monthly or less (1) 
Two to four times a month (2) 
Two to three times per week (3) 
Four or more times a week (4)      
______ 
2. How many drinks containing alcohol do you have on a typical day when you are drinking? 
1 or 2 (0)  
3 or 4 (1)  
5 or 6 (2)  
7 to 9 (3)  
10 or more (4)        
______ 
3. How often do you have six or more drinks on one occasion? 
 
Never (0)  
Less than Monthly (1) 
Monthly (2)  
Two to three times per week (3) 
Four or more times a week (4)  
______ 
TOTAL SCORE 
Add the number for each question to get your total score.    ______ 
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Table 2.3. US standard drink [133] 
 
Equivalents of 13.7 grams ethanol 
12 oz. of beer or cooler 5% ethanol 
8–9 oz. of malt liquor 7% ethanol 
5 oz. of table wine 12% ethanol 
3–4 oz. of fortified wine (such as sherry or port)  17% ethanol 
2–3 oz. of cordial, liqueur, or aperitif  24% ethanol 
1.5 oz. of brandy (a single jigger)  40% ethanol 
1.5 oz. of spirits (a single jigger of 80-proof gin, vodka, whiskey, etc.)  40% ethanol 
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Figure 2.1. Distribution of drinking levels, for men 18 years of age and older: United Status, 
National Health Interview Survey, 1997-2008 [134]. Drinking levels: abstainer, fewer than 
12 drinks in lifetime or no drinks in the past year; light drinker, on average, 3 or fewer drinks 
per week in the past year; moderate drinker, on average, no more than 14 drinks per week for 
men in the past year; and heavy drinker, on average, more than two drinks per day for men in 
the past year. 
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Figure 2.2. Overview of the association between alcohol consumption and HIV 
seroconversion 
  
 
CHAPTER III 
METHODS 
Study population 
 The Multicenter AIDS Cohort Study (MACS), an ongoing prospective study of the 
natural and treated history of HIV infection in MSM, was initiated in 1983 by sites located in 
the metropolitan areas of Baltimore, Maryland/Washington DC; Chicago, Illinois; Pittsburgh, 
Pennsylvania, and Los Angeles, California [135]. From April 1984 through March 1985, 
4,954 HIV negative and positive men were recruited into the MACS. To increase minority 
enrollment, an additional 668 men were recruited from 1987-91, of whom 433 (65%) were 
non-Caucasian. In 1993, 1,710 seronegative participants (approximately half those still being 
followed) were administratively censored by the study [136]. In 2001, the four clinical sites 
enrolled an additional 1,350 participants including 662 HIV seronegative men. Thus, a total 
of 6,972 men have been enrolled in the MACS of whom 3,725 are HIV negative men with 
38,220 person-years of follow-up observed through 1 January 2008. 
 MACS participants were recruited through publicity (e.g., newspaper articles, 
advertisements); political groups, community centers and medical facilities catering to MSM; 
health care provider referral; and in some cities, active recruitment at gay bath houses and 
bars [135]. At enrollment, participants completed surveys in which they detailed their 
behaviors over the previous two years. At subsequent semiannual visits they were asked to 
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report only on behaviors in the 6 months since their last study visit. These visits could last 
over 3 hours in duration. Study personnel maximized retention by collecting identifying 
information on participants including social security and driver’s license numbers and by 
collecting information on close contacts or personal physicians [137]. When participants 
failed to arrive for scheduled follow-up visits, the MACS attempted to resurrect contact 
through phone calls, mail, contacts and available databases. When participants could not 
come to the study site, they were allowed to complete portions of the survey at home and 
provide blood samples through the mail. 
 
Data collection and measures 
Standardized interviewer-administered and/or audio computer-assisted structured 
interview (ACASI) questionnaires at each semiannual study visit collected information on 
demographics, risk behaviors, psychosocial characteristics (e.g., depression), illnesses, 
utilization of health services, and an extensive medication use inventory using medication 
photographs for select medications for prophylaxis or treatment. The demographic and risk 
behavior portions of the questionnaire were interviewer-administered initially and were 
converted to ACASI for newly enrolled participants beginning in October 2001 and at 
follow-up visits for all participants in October 2002. The four clinical sites are experienced in 
maintaining the cohort and core laboratories, conducting data collection and optimizing the 
use of resources.  
 
Self-reported Alcohol Consumption  
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The MACS assesses participant alcohol consumption using a self-administered 
quantity-frequency questionnaire at semi-annual study visits. As part of the questionnaire, a 
drink of alcohol is defined for the participant as equivalent to any of the following: 12 ounces 
of beer, 4 ounces of wine, 1.5 ounces of liquor or a mixed drink with that amount of liquor. 
Instructions in the MACS were modified to define a 5 oz glass of wine as standard beginning 
at visit 40 (October 1, 2003 - March 31, 2004). The latter definition mirrors the current 
standard drink measures applied by the U.S. Food and Drug Administration [138] (Table 
3.1). We treated the definitions at different visits as interchangeable. 
 Participants are asked to estimate their drinking frequency over the period since the 
last visit: at least 1/day, nearly every day, 3-4/week, 1-2/week, 2-3/month, 1/month, 6-
11/year, 1-5/year, or never (Table 3.1). From this response, we calculate the corresponding 
weekly drinking frequency multiplier for each participant of 7, 5.5, 3.5, 1.2, 0.625, 0.25, 
0.106, and 0.058. The usual quantity of drinks consumed on a drinking day is elicited with 
options of: 1-2, 3-4, 5-6, or 7-9, 10 or more drinks/day, which we transform into average 
drinking day counts of 1.5, 2.5, 5.5, 8 and 11 (Table 3.1). From these, we defined self-
reported average weekly alcohol consumption ( A ) for the prior six-month period as the 
product of the weekly probability of drinking and drinking intensity (i.e., quantity-
frequency). We chose weekly alcohol consumption for analysis, as it is a measure easily 
communicated to clinicians and applied to other research.  
 
Human subjects 
Data and specimen collection in the MACS have been approved by institutional 
review boards at all participating institutions. During the consent for this study, participants 
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were informed that both their responses to questionnaires and the biological samples they 
provided would be used to answer research questions related to HIV risk factors and 
etiology; they were also informed that they could withdraw participation and refuse the use 
of their data at anytime.  
A data use agreement was put into place between the University of North Carolina 
and the MACS, which limited potential breaches of confidential information to persons 
outside of the study by using only de-identified participant information, limiting covariate 
data to variables pre-specified in the aims of this research, and restricting data access to 
authorized individuals at the University of North Carolina, at Chapel Hill. The aims of this 
dissertation were deemed “not human subjects research” by the University of North Carolina 
Public Health-Nursing Institutional Review Board. 
 
Statistical methods for aim 1 
 The aim of the first dissertation manuscript was to identify time-independent and 
time-dependent predictors of alcohol consumption in HIV-seronegative men enrolled in the 
MACS. The structure and general practices of the MACS have been described previously. 
Here we focus on the variables and statistical methods specific to this analysis. 
 
Descriptive methods 
We examined the distribution of alcohol consumption (drinks/week) and all other 
continuous covariates (Table 3.2) graphically and by examining their means and standard 
deviations or medians and interquartile ranges at each visit and across visits. As appropriate, 
we considered categorization or restricted cubic splines for continuous variables. The latter 
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approach creates a smoothly-joined piecewise polynomial that allow for a flexible non-linear 
relation between continuous exposures and an outcome [139]. For dichotomous and 
categorical potential predictors we characterized the percentage of the population for each 
level of the predictor.  
 
Outcome assessment 
At each semi-annual study visit, participants were asked about their consumption of 
alcohol as part of a behavioral questionnaire that also asked about illicit drug use and sexual 
activity in the past six months. The few (< 1%) reports of 10 or more drinks per drinking-day 
were classified as 12 drinks. Participants were censored at the first visit at which they failed 
to answer questions about their alcohol consumption or at their last study visit when they 
were not observed subsequently for a period of more than two years regardless of whether 
they ultimately returned for visits thereafter. 
 
Predictors of alcohol consumption 
 The predictors of alcohol consumption considered in this aim and how each was 
categorization for modeling are presented in Table 3.2. Predictors were selected from 
variables associated with alcohol consumption in previous cross-sectional analyses, and the 
results of a longitudinal study of alcohol consumption among injection drug users at risk for 
HIV [140]. Where restricted cubic splines were chosen, these were implemented with the 
Harrell’s %DASPLINE SAS macro available at: 
http://biostat.mc.vanderbilt.edu/wiki/pub/Main/SasMacros/survrisk.txt. With respect to illicit 
drug use, we explored several different categorizations. We first considered the use of each 
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of three most common illicit drugs (marijuana/hash, poppers and cocaine/crack cocaine) 
individually and categorized them by frequency: each drug category alone, each pair of these 
drug categories and all three drug categories used in combination as had been done in 
previous work in this cohort [141]. In ancillary analyses we also considered there use of any 
versus no illicit drugs. We anticipated that prior alcohol consumption would strongly predict 
subsequent consumption, and treated this predictor as an effect modifier. 
 
Models 
Multivariable logistic regression was used to model the log-odds of reporting any 
drinking at the current visit as a function of baseline predictors and time-dependent 
predictors, lagged one visit. All logistic regression models were stratified by drinking status 
at the prior visit. Multivariable lognormal regression models were used to model alcohol 
consumption among current drinkers. These models produce effect measure estimates 
referred to as the median ratio [142]. For categorical predictors, the median ratio represents 
the expected median number of drinks per week consumed by one group divided by the 
median number of drinks per week consumed by those in the reference group. The use of 
multiple observations per participant results in correlated measurements of alcohol within 
participants. To account for this, we used robust variance estimates [143], which are 
equivalent to generalized estimating equations [144] with a diagonal/independent working 
covariance matrix [145]. This approach provides estimation of the coefficients for intercepts 
and predictors using a maximum likelihood approach while the variance estimates for each 
parameter are allowed to inflate in the presence of the positive dependence between alcohol 
consumption. Precision was assessed with 95% CLs. 
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Statistical methods for aim 2 
The aim of the second dissertation manuscript was to use marginal structural models 
to characterize the association between alcohol consumption and HIV seroconversion for 
MACS participants. As part of this aim, we characterized the joint effects of alcohol 
consumption and high risk sexual behavior (specifically unprotected receptive anal 
intercourse). Here we first describe how both exposures are implemented in this aim. Next, 
we give an overview of marginal structural models as they are implemented for a single 
exposure. We conclude with a description of the joint marginal structural model used in the 
analysis of this paper. 
 
Exposure definitions 
The primary exposure of interest for this aim was alcohol consumption reported and 
collected as describe previously. We initially intended to define quantiles of alcohol 
consumption based on the distribution of consumption of alcohol across person time in the 
study population. However, after considering the large proportion of moderate and 
nondrinking observed in Aim 1 and experimenting with tertiles, quartiles and quintiles of the 
alcohol consumption of cases and non-cases, we ultimately decided to use previously defined 
levels of drinking [138]. Specifically, we considered three levels of drinking: nondrinkers, 
moderate drinkers (1-14 drinks/week), and heavy drinkers (>14 drinks/week) based on 
reports averaged over the prior two visits (approximately one year).  
The secondary exposure was the number of unprotected receptive anal intercourse 
partners reported, hereafter referred to as partners. Participants self-reported the number of 
 30 
 
partners they have had at each semiannual visit. The few (<1%) reports of more than six 
partners since the previous visit were reset to the median of those with more than six partners 
(10 partners). In joint models, we considered two levels of receptive anal intercourse: one or 
fewer partners and multiple partners. Similar to alcohol measures, we averaged the number 
of partners over the previous two visits. 
 
Outcome assessment 
HIV status was determined from blood specimens tested by enzyme-linked 
immunosorbent assay and was confirmed by Western blot at each semiannual visit. 
Participants are classified as being seronegative if they had a negative or equivocal enzyme 
immunoassay result or a negative or indeterminate confirmatory Western Blot result. 
Individuals with positive HIV test results received outside of the study have these results 
confirmed through the same algorithm. All laboratories have been certified by the standards 
of the Clinical Laboratory Improvement Amendment regulations and by the National 
Institute of Allergy and Infectious Diseases.  
Participants were followed from their baseline visit until HIV seroconversion, death, 
loss to follow-up, or administrative censoring. The midpoint between dates of the last 
seronegative and the first seropositive test was taken as the estimated date of HIV 
seroconversion; when this date was more than one year after the last seronegative test date (n 
= 33), participants were classified as lost to follow-up at one year post-last seronegative test 
date. Follow-up practices in the MACS cohort have been described previously [137]. Briefly, 
death information was obtained from death certificates, the Social Security Death Index, the 
National Death Index, autopsy records, and other notification sources. We censored follow-
up for participants who failed to attend study visits for more than one year at the minimum 
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of: their date of death (if applicable), one year after their last visit, or 1 January 2008 (date of 
administrative censoring). All remaining seronegative participants seen after 1 January 2007 
were administratively censored on 1 January 2008. 
 
Marginal structural models 
Overview 
 It has been established that standard statistical approaches (i.e., stratification, 
regression) used to adjust for time-varying confounding in observational longitudinal data  
may produce biased effect estimates in situations where there are time-updated confounders 
that are also causal intermediates even under the null hypothesis of no effect [54]. Figure 3.1, 
a directed acyclic graph depicting the association between alcohol consumption and HIV 
seroconversion, is simplified to illustrate how this might occur when only a single time-
updated confounder is concerned. In this case, drug use is a time-updated covariate that is a 
risk factor for both HIV seroconversion and subsequent alcohol consumption, and alcohol 
consumption predicts subsequent drug use. Standard approaches would adjust for drug use 
because it is a confounder of the relationship of interest. However, as is clear from the figure, 
adjusting for drug use would block part of the indirect effects of alcohol consumption 
mediated through illicit drug use [54]. Additionally, adjustment might induce a selection bias 
when confounders are affected by prior levels of the main exposure [146].  
Several approaches, known collectively as “g-methods” are available for the 
estimation of effects of time-varying exposures in the presence of time-dependent 
confounding from observational data: g-computation algorithm formula, g-estimation of 
structural nested models, and inverse probability weighted (IPW) estimation of marginal 
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structural models [147]. We select the last approach, which is easily implemented in standard 
statistical software and suitable when the null hypothesis (i.e., no effect of alcohol on HIV 
seroconversion) has not been excluded. Like the other g-methods, the marginal structural 
model estimates contrasts in potential (counterfactual) outcomes.  
 
Notation 
 Failure time is denoted by T  and was measured continuously in days since the 
participant enrolled in the MACS. Study visits are indexed by j  and ranged from study entry 
j =0 to visit j =47. In the methods that follow, capital letters represent random variables and 
lowercase letters represent possible values of random variables. ijA is a time-updated variable 
indicating alcohol consumption by participant i reported at visit j . Similarly, the time-
updated number of partners is given by ijR . The vector ijL indicates values of the time-
updated predictors of HIV seroconversion, alcohol consumption and unprotected receptive 
anal intercourse partners, which include depressive symptoms, illicit drug use, current 
smoking status and sexually transmitted infections. Time-independent covariates whose 
values do not vary after measurement at baseline (i.e., race, ethnicity, enrollment age, city, 
and educational attainment) are denoted by iV . The subscripted i  is generally suppressed in 
the following formulae for simplicity. Potential outcomes are represented as 0jaT   , 1jaT  , 
2ja
T  or the time to HIV seroconversion that would have been observed had the level of 
alcohol consumption been set to 0, 1-14 or >14 drinks/week, respectively. ijC  is a 
dichotomous variable indicating if the participant was censored due to loss to follow-up by 
that visit or not. 
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 Model assumptions 
Assuming no unmeasured confounding, no informative censoring, no model 
misspecification, consistency, and positivity, marginal structural models yield asymptotically 
consistent estimates of the true causal effect [54, 148, 149].  
The assumption of no unmeasured confounding is well appreciated in epidemiology; 
it is reviewed here in the language of potential outcomes and referred to as conditional 
exchangeability, defined as ,
ja
T A V L . Here the potential failure time is independent of 
observed exposure within levels of measured covariates. Analogously, potential failure times 
are assumed to be independent of censoring within levels of measured covariates. 
Under consistency, we understand that for every subject with observed exposure
i j jA a , the potential outcome jaT is equal to that subject’s observed outcome, ijT . While in 
experimental studies consistency is generally taken for granted because the intervention is 
assigned and often administered by the researcher; in observational studies such as this one, 
this assumption requires careful consideration and assessment of the exposure of interest. 
Stated differently, there should not be multiple versions the exposure. For example, in this 
case it means that we must able to assume that it is of consequence with respect to his HIV 
outcome if a subject consumes 7 drinks/week at a single sitting or one drink per day; or if the 
alcohol consumed came from distilled spirits instead of beer; or if the alcohol was consumed 
shortly prior to sexual activity instead of afterwards.  
The positivity assumption states that Pr[ , ] 0j jA a   V v L l  for all 
Pr[ , ] 0j  V v L l  in the target population or said differently that there are both exposed 
and unexposed individual at all levels of the observed confounders [148, 150]. In 
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observational data, positivity may be violated by chance or deterministically [151]. We 
address this assumption further in our description of the weight construction below. 
 
Model 
In the Cox proportional hazards marginal structural model the potential failure time, 
ja
T ,  represents a subject’s time to event with (possibly contrary to fact) exposure equal to ja  
[152, 153].  
   0 exp( )a jT j jt t a    V V  
Here,  
a jT
t V  is the hazard rate of 
ja
T  at t, conditioned on the vector of baseline covariates 
V ;  0 t  is an unspecified baseline hazard function; and  exp   is the so-called causal 
hazard ratio (HR) for the effect of an increase of one level of alcohol consumption averaged 
across follow-up [54]. For example, one might be interested in contrasting the time to HIV 
seroconversion in a population in which everyone was a heavy drinker compared to the time 
to HIV seroconversion in the same population if no one drank alcohol. By the consistency 
assumption, only the outcome in a given individual under the exposure he truly experienced 
is observed by the researcher. The time to HIV seroconversion for a heavy drinker had he 
been a nondrinker is therefore a missing value.   
We fit the above model using stabilized IPW to address confounding and selection 
biases due to measured variables. IPW is an extension of the Horvitz-Thompson estimator 
used to handle nonresponse in survey sampling [154]. Continuing the example from above, 
other men contributing data to the cohort at that time and with identical covariate and alcohol 
consumption histories, but different levels of current alcohol consumption, are weighted to 
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represent the outcome of the heavy drinker, had he not consumed alcohol heavily. If no 
unmeasured confounding is present, alcohol consumption will be unassociated with past 
history of measured covariates in the weighted pseudopopulation, but the HR of interest will 
remain the same as in the original population.  
The general form of our stabilized exposure weights is given below, where alcohol 
consumption jA   may take on discrete values from the range of observed drinks/week 
consumed (e.g., 5 drinks/week). Overbars refer to the history of a variable  
(  1 2,j jA A A A  ).  
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The denominator of these weights has been described informally as the probability that a 
subject had his own observed exposure, given his covariate history [152]. We mitigated the 
impact of highly variable weights by stabilizing our weights by the numerator [54, 148]. As 
part of this stabilization, baseline covariates, V, were included in the numerator and 
denominator of these weights and must therefore be adjusted for in the final Cox model in 
order to account for confounding by time these time fixed covariates. Practically, these 
weights were calculated from the observed data using pooled cumulative logistic regression 
[155] in SAS PROC LOGISTIC using a cumulative logistic link. 
Censoring weights were similarly fit for both the censoring due to lost to follow-up 
and censoring due to death. Weights for censoring due to loss to follow-up are given by: 
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Note that we did not consider participants who were administratively censored by the 
study to be drop outs as we assumed that the procedures implemented in the MACS for this 
process excluded individuals at random.
 
 
Joint marginal structural Cox models 
 The previous exposition of methods used for this analysis considered only a single 
exposure. While the effect of alcohol consumption was of primary interest in this work, we 
hypothesized there was an interaction with high risk sexual behavior, another time-updated 
behavior. An approach to interaction in marginal structural models was first detailed by 
Hernan, et al. [156], but to our knowledge has seen limited application [157-159]. Whereas 
the results from marginal structural model described previously will, under the stated 
assumptions, approximate the results of a randomized trial in which a single treatment was 
randomized; the results of the joint marginal structural model will give the results one would 
have seen had two treatments been randomized and correspond to an intervention in which 
we could imagine manipulating both exposures. A joint model requires that the previously 
stated assumptions hold for both exposures. 
 This final joint marginal structural Cox proportional hazards model for HIV 
seroconversion included as regressors alcohol consumption averaged over the prior year 
(categorized as none, moderate (1-14 drinks/week), or heavy(>14 drinks/week), number of 
receptive anal intercourse partners averaged over the prior year (categorized as ≤ 1 or >1), 
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and their product terms. Additionally, the final model includes baseline covariates used to 
stabilize the IPW. 
   
, , 0 0
exp( )
a r cj jT j j j j j j j
t t a r a r         V V  
We presented HRs and 95% CLs using robust variances based on this model. Departure from 
proportional hazards for the alcohol and partner effects were assessed through models that 
included exposure by time and exposure by log-time product terms and by visual inspection 
of log(-log)-survival plots. The contribution of the interaction term was assessed using a joint 
robust Wald 2 test. We did not find this interaction to be meaningful on the multiplicative 
scale and therefore also include results from models that exclude that term. We went on to 
consider departure from additivity using the relative excess risk due to interaction (RERI) 
using methods for the proportional hazards model developed by Li and Chambless [160]. 
This RERI is interpreted as the increased risk due to additive interaction after accounting for 
confounders. SAS code from the authors [161] was adapted to calculate RERIs from the 
marginal structural model. Wald 2 trend tests were used across levels of alcohol 
consumption with the median (0, 5, and 22 drinks/week, respectively) assigned for each of 
the three levels of alcohol consumption considered. 
Exposure weights were calculated from a pair of cumulative pooled logistic 
regression models as described previously [155]: each accounted for the following 
dichotomous time-updated confounders, lagged one visit: elevated depression symptoms, 
smoking status, use of illicit drugs and self-reported sexually transmitted infection. In 
addition, the weight model for partner number also included concurrent alcohol consumption. 
Note, we needed to include concurrent alcohol consumption in the partner number weights 
because of the multiplication rule of conditional probability, which states that when two 
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events are dependent, the probability of both occurring is given by: 
   Pr , Pr PrA R A R A    . Therefore, to produce joint weights, one of the two exposure 
weights needed to include the concurrent level of the other exposure. 
These weights were stabilized to improve precision by alcohol consumption history 
(product terms between alcohol consumption at 6, 12, and 18 months prior and restricted 
cubic splines with knots at the 5th, 27.5th, 50th, 72.5th and 95th percentiles for consumption at 
those times), partner history (product terms between partner number at 6, 12 and 18 months 
prior), and time-independent covariates measured at baseline [148].  
The final weights were calculated as the product of exposure, censoring, and death 
weights. These weights have an expected mean of 1 and reduced variance compared to 
unstabilized weights [54, 148]. We graphically examined the distribution of our weights and 
calculated the mean and variance. Based on the distribution of the weights, additional 
truncation [148] was not deemed necessary. Furthermore, the behavior of the weights, 
suggests that nonpositivity is not a major concern. 
We compared our results to those from a standard Cox proportional hazards model 
[162] that includes main effects of alcohol consumption and unprotected receptive anal 
intercourse partners and their interaction. 
   0 exp( ' ' ' )j j j jt t A R A R        
We additionally compared these results to those from a model that adjusted for both baseline 
and time-updated confounders, lagged one visit.  
    '' '' ''0 1, exp( ' )jj j j j j j j jt t a r a r          L V L V  
We also considered as a comparison models that adjusted for concurrent values of time-
updated values, but found that these gave similar results. 
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Finally, we described the public health impact of our findings by calculating the 
excess fraction [163] of HIV seroconversion associated with heavy drinking: 
  heavy v. <heavy
heavy v. <heavy
1
Excess risk ( )
HR
p
HR
  
Where p is the proportion of heavy drinkers who reduced their alcohol consumption to at 
least moderate levels and could vary between 0 and 1. This excess risk was interpreted as the 
percentage of HIV seroconversions that could be avoided if a given percentage of heavy 
drinkers reduced their alcohol consumption.  
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Table 3.1. MACS follow-up visit questionnaire, semiannual visit 
  
41. The next set of questions are about alcoholic beverages. They may seem similar, but they 
are asked in a slightly different way. 
Please answer each of the following questions for the past 6 months. 
 
A. How often have you had drinks containing alcohol? 
o Never STOP- SKIP TO Q41K 
o Less than monthly  
o Monthly  
o Weekly  
o Daily or almost daily 
 
B. During the past 6 months, how many drinks containing alcohol have you had 
on a typical day when you are drinking? (A “drink” is defined as one 12-
ounce beer, one 5-ounce glass of wine, or one mixed drink with 1 and ½ 
ounces of 80 proof hard liquor.) 
o 1 or 2 
o 3 or 4 
o 5 or 6 
o 7 to 9 
o 10 or more 
o None 
 
C. During the past 6 months, how often have you had six or more drinks on one 
occasion? (A “drink” is defined as one 12-ounce beer, one 5-ounce glass of 
wine, or one mixed drink with 1 and ½ ounces of 80 proof hard liquor.) 
o Never 
o Less than monthly 
o Monthly 
o Weekly 
o Daily or almost daily 
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Table 3.2. Covariables 
Variables Classification Type 
 
Demographic 
Race/ethnicity Categorical: 
Black 
White Hispanic 
White non-Hispanic 
Time-independent 
Age at enrollment Restricted cubic spline  Time-independent 
Education level Dichotomous: 
Less than College 
College Graduate 
Time-independent 
Behavioral   
Number of receptive anal sex 
partners 
Categorical: 
0 
1 
>1 
Time-dependent 
Center for Epidemiologic Studies 
Depression Scale Score (Table 3.3) 
 
Dichotomous  
>16 
≤16 
Time-dependent 
Drug Use   
Current smoking (tobacco) Dichotomous (Yes/No) Time-dependent 
Marijuana/Hashish use Dichtomous (Yes/No) Time-dependent 
Cocaine/crack cocaine use Dichtomous (Yes/No) Time-dependent 
Poppers/amyl, butyl or isopropyl 
nitrite use 
Dichtomous (Yes/No) Time-dependent 
Other   
Enrollment (time) Restricted cubic spline Time-independent 
Enrollment city Categorical Time-independent 
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Table 3.3. Center for Epidemiologic Studies- Depression scale [164] 
 
CENTER FOR EPIDEMIOLOGIC STUDIES—DEPRESSION SCALE 
Circle the number of each statement which best describes how often you felt or behaved this 
way – DURING THE PAST WEEK. 
 Rarely or 
none of the 
time (less 
than 1 day) 
Some or a 
little of the 
time (1-2 
days) 
Occasionally or a 
moderate amount 
of the time (3-4 
days) 
Most 
or all 
of the 
time 
(5-7 
days) 
During the past week: 0 1 2 3 
1) I was bothered by things that 
usually don’t bother me 
0 1 2 3 
2) I did not feel like eating; my 
appetite was poor 
0 1 2 3 
3) I felt that I could not shake 
off the blues even with help 
from my family and friends 
0 1 2 3 
4) I felt that I was just as good 
as other people 
0 1 2 3 
5) I had trouble keeping my 
mind on what I was doing 
0 1 2 3 
6) I felt depressed 0 1 2 3 
7) I felt that everything I did 
was an effort 
0 1 2 3 
8) I felt hopeful about the future 0 1 2 3 
9) I thought my life had been a 
failure 
0 1 2 3 
10) I felt fearful 0 1 2 3 
11) My sleep was restless 0 1 2 3 
12) I was happy 0 1 2 3 
13) I talked less than usual 0 1 2 3 
14) I felt lonely 0 1 2 3 
15) People were unfriendly 0 1 2 3 
16) I enjoyed life 0 1 2 3 
17) I had crying spells 0 1 2 3 
18) I felt sad 0 1 2 3 
19) I felt that people disliked 
me 
0 1 2 3 
20) I could not get “going” 0 1 2 3 
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Figure 3.1. Directed acyclic graph illustrating time-varying confounding 
 
 
 
 
CHAPTER IV 
A LONGITUDINAL STUDY OF ALCOHOL CONSUMPTION AMONG US MEN WHO 
HAVE SEX WITH MEN, 1984-2007 
Introduction 
Alcohol is a popular recreational drug in the United States (US). Consumption 
produces both stimulatory and anxiolytic physiologic effects, which may be enhanced when 
its use is coupled with the expectation of positive social, emotional or physical effects [165]. 
Greater than moderate alcohol consumption is linked to adverse health consequences 
including cancer, psychiatric illness, cardiovascular disease, liver cirrhosis, and injury [166]. 
Alcohol consumption is indirectly linked to the acquisition of sexually transmitted infections, 
including HIV, in large part as a result of increased sexual risk-taking by intoxicated persons 
[2, 3, 11, 60]. Moreover, use of illicit drugs while under the influence of alcohol may 
increase high risk drug use behaviors (e.g., needle sharing) [167]. Understanding the 
longitudinal predictors of alcohol consumption may assist in the development of timely, 
targeted interventions to reduce harmful alcohol consumption and its adverse consequences. 
This knowledge would also provide insight into potential confounders when studying the 
health effects of alcohol consumption.  
Studies in the general population suggest that alcohol consumption decreases with 
age; whereas higher consumption is associated with male gender, white race, being 
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unmarried, having a higher educational level, and smoking [168, 169]. Few longitudinal 
studies of alcohol consumption have focused on adult men who have sex with men (MSM). 
Alcohol consumption among MSM should be considered separately from men in the general 
population, because MSM are thought to consume alcohol at higher levels [39, 40] and their 
substance use behaviors may have changed in response to the US HIV epidemic [44].  
Repeated assessments of potential predictors and alcohol consumption are necessary 
to explore the association between time-updated variables and alcohol consumption because 
many of the factors that may predict subsequent alcohol consumption (e.g., drug use, 
depression) may also be affected by prior alcohol consumption. Therefore, assuring the 
correct temporal ordering is essential to making inferences. In this study, we use self-
reported data on alcohol consumption from MSM in the prospective Multicenter AIDS 
Cohort Study (MACS). The current study is restricted to men at risk for HIV acquisition, 
because the symptoms of HIV, the receipt of HIV primary care, and the side effects of 
antiretroviral medication may all modify drinking behavior and suggest that MSM with HIV 
should be considered separately [30, 170, 171]. We investigate the association of time-fixed 
and time-updated factors with subsequent alcohol consumption between 1984 and 2007. 
 
Materials and methods 
Study sample 
The study sample consisted of a subset of participants enrolled in the MACS, an 
ongoing study of the natural history of HIV infection among MSM in the US metropolitan 
areas of Baltimore, Maryland/Washington, DC; Chicago ,Illinois; Los Angeles, California 
and Pittsburgh, Pennsylvania [135]. The MACS enrolled 6,972 men: 5,622 between 1984 and 
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1992 and 1,350 in 2001. Of these 6,972 men, 4,029 were HIV-seronegative at their baseline 
visit.  
Participants are followed semiannually at study visits that include physical 
examinations, blood draws and standardized questionnaires (including the Center for 
Epidemiologic Studies Depression (CES-D) scale [164]). The demographic and risk behavior 
portions of the questionnaire were interviewer-administered initially and were converted to 
audio computer-assisted self-interview for newly enrolled participants beginning in October 
2001 and at follow-up visits for all participants in October 2002 because audio computer-
assisted self-interview was found to yield higher reports of sensitive and high risk behaviors 
[172]. Informed consent was obtained from all participants in compliance with the 
appropriate ethical committee at each study site. Study design details and questionnaires are 
available at http://www.statepi.jhsph.edu/macs/macs.html.  
We restricted the study sample to the 3,651 of 4,029 HIV-seronegative men who 
attended a first follow-up visit within two years of their initial study visit. Participants were 
followed through their last planned study visit before 1 January 2008 (administrative 
censoring), death or HIV seroconversion. Dates of HIV seroconversion were determined 
from blood specimens tested by enzyme-linked immunosorbent assay and confirmed by 
Western blot. Participants were classified as lost to follow up at their last study visit when 
they were not observed subsequently for a period of more than two years regardless of 
whether they ultimately returned for visits thereafter. Participants were censored at the first 
visit at which they failed to answer questions about their alcohol consumption. 
 
Measurements 
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We defined alcohol consumption as the typical number of drinks per week in the last 
6 months, calculated as the product of the reported average number of drinking-days per 
week and the average number of drinks per drinking-day. Participants reported drinking at 
least daily, nearly every day, 3-4 times per week, 1-2 times per week, 2-3 times per month, 
monthly, 6-11 times per year, 1-5 times per year or never. A drink was defined as one 12-
ounce beer, one 4 or 5-ounce glass of wine, or one mixed drink with 1.5 ounces of 80 proof 
hard liquor. Participants reported the category that best corresponded to the number of drinks 
they consumed per drinking-day: 0, 1-2, 3-5, 6-9, or >10. The few (<1%) reports of 10 or 
more drinks per drinking-day were classified as 12 drinks. For graphical presentation of 
overall alcohol consumption, heavy drinking was defined as greater than 14 drinks per week 
[138]; all other consumption was considered moderate.  
Potential predictors of alcohol consumption were identified a priori by a review of 
the literature and included the following covariates measured at the baseline study visit: age, 
race, and whether the participant graduated from college. Time-updated potential predictors 
reflected behavior in the 6-12 months temporally prior to alcohol consumption. They 
included illicit drug use, elevated depression symptoms (CESD >16), current smoking status, 
and the number of partners with whom the participant practiced unprotected receptive anal 
intercourse (none, 1 or ≥ 2). We considered three classes of illicit drugs: marijuana or hash, 
poppers (i.e., inhaled alkyl nitrites), and cocaine, including crack cocaine. Time-updated 
predictors were lagged one visit to ensure values were temporally prior to reported alcohol 
consumption (i.e., 6-12 months prior). We anticipated that prior alcohol consumption would 
strongly predict subsequent consumption, and treated this predictor as an effect modifier; we 
examined whether predictors of alcohol consumption varied by prior drinking status.  
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Missing data were rare. Specifically, data were missing for 7% and 5% of variables at 
baseline for the number of unprotected receptive anal intercourse partners and CES-D, 
respectively and was missing for <2% of all other variables. For values missing at baseline 
we imputed the mode. For missing values over follow-up, the value from the previous visit 
was carried forward (number of unprotected receptive anal intercourse partners, 6%; CES-D, 
4%; and all others, <2%).  
Statistical Analysis 
We calculated adjusted odds ratios (OR) to estimate the association between potential 
predictors and drinking status, modeled as any versus no drinking at each visit. We stratified 
results by whether the participant had reported any alcohol consumption at the prior visit and 
modeled the probability of any drinking at the current visit. Because the distribution of 
alcohol consumption was expected to be right-skewed, we modeled the logarithm of alcohol 
consumption among current drinkers. Lognormal regression models produce effect measure 
estimates referred to as the median ratio [142]. For categorical predictors, the median ratio 
represents the expected median number of drinks per week consumed by one group divided 
by the median number of drinks per week consumed by those in the reference group. In the 
lognormal model, the number of drinks consumed per week reported at the prior visit was 
included as a restricted cubic spline with knots at the 5th, 27.5th, 50th, 72.5th and 95th 
percentiles [173]. Splines create a smoothly-joined piecewise polynomial that allow for a 
flexible non-linear relation between prior alcohol consumption and current alcohol 
consumption [139]. For all models, 95% confidence limits (CL) with robust variances were 
used to account for the dependence incurred by multiple visits by each participant [143]. We 
included the following variables in all models: time-on-study, modeled as a cubic spline with 
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knots at the same locations as given above; baseline visit date, modeled as a cubic spline with 
knots at the same locations as given above; and indicators for study site. Analyses were 
conducted using SAS version 9.2 (SAS Institute, Inc.; Cary, North Carolina).  
 
Results 
At baseline, the 3,651 men were a median of 33 years of age (interquartile range 
(IQR): 28-39), 12% of black race, 6% Hispanic and 59% had completed college (Table 4.1). 
As of 1 January 2008, they had been followed for a median of 5.7 years (IQR: 2.5-10.3). 
Thirty-seven (1%) participants died during follow up, 433 (12%) acquired HIV infection, 524 
(14%) were lost to follow-up, 342 (9%) were censored when they failed to report alcohol 
consumption, and 2,315 (63%) were administratively censored. Among all participants, the 
median alcohol consumption reported was 5 drinks per week (IQR: 1-12) at baseline. Among 
self-reported drinkers, median alcohol consumption was 5 drinks per week (IQR: 2-12). 
Alcohol consumption decreased over follow-up: abstention from alcohol consumption 
was reported at 26% of follow-up visits versus 18% of baseline visits (p <0.0001). Median 
alcohol consumption was 2 drinks per week (IQR: 0-8) over 47,261 visits (Appendix 2.4.1). 
Self-reported drinkers maintained a median alcohol consumption of 5 drinks per week (IQR: 
1-12). As participants aged, the proportion abstaining from alcohol appeared to increase; 
however the proportion reporting heavy drinking did not appear to decrease (Figure 4.1, 
Panel A). A similar trend was apparent over calendar time: in 1984, 16% of participants were 
nondrinkers and 17% were heavy drinkers; in 2003, 29% were nondrinkers and 11% were 
heavy drinkers (Figure 4.1, Panel B).  
Use of marijuana/hash, poppers and cocaine/crack cocaine was common (67%, 52%, 
and 26% of participants used each drug in the two years prior to their baseline visit, Table 
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4.1). Injection drug use was uncommon (<1%) as was methamphetamine use (4%), which 
furthermore was not captured consistently over follow-up. Just 7% of the cohort reported use 
of any other drugs, including heroin. We therefore considered these three most common 
illicit drugs categories as potential predictors and model the use of each drug category alone, 
each pair of these drug categories and all three drug categories used in combination 
(Appendix 2.3.2) [141]. In ancillary analyses we consider the use of any versus none of these 
three drug categories.  
Table 4.2 presents results from the 75% of study visits preceded by a visit at which 
any alcohol consumption was reported. Among drinkers at the prior visit, the number and 
type of illicit drugs used were associated with any current drinking: current drinking was 
reported at 97% of visits by users of marijuana/hash, poppers and cocaine/crack and 91% of 
visits by non-users of these three drug categories (Table 4.2). In the ancillary multivariable-
adjusted model that included any illicit drug use versus none, the OR was 2.78 (95% CL: 
2.58, 3.01). In our main analysis, the multivariable-adjusted OR for any current drinking 
comparing users of marijuana, poppers and cocaine to non-users was 2.90 (95% CL: 2.21, 
3.80). Among drinkers at the prior visit, college graduates were more likely to report any 
current drinking (94%) than non-graduates (92%); whites were more likely to report any 
current drinking (94%) than blacks (87%); and men without elevated depression symptoms 
were more likely to report any current drinking (94%) than those with elevated depression 
symptoms (91%). All these observed associations persisted after multivariable adjustment 
(Table 4.2).  
Table 4.3 presents results from the 25% of study visits that were preceded by a visit at 
which no alcohol consumption was reported. Among nondrinkers at the prior visit, illicit 
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drug use was associated with current drinking: current drinking was reported at 32% of visits 
by users of marijuana/hash, poppers and cocaine/crack and 14% of visits by non-users. The 
multivariable-adjusted OR for any current drinking by men who used marijuana/hash, 
poppers and cocaine/crack cocaine compared to men who used no drugs was 2.93 (95% CL: 
1.79, 4.78). Among nondrinkers at the prior visit, the use of individual drug categories or 
pairs of drug categories was also associated with reports of any current drinking. After 
multivariable adjustment, use of cocaine/crack cocaine was the strongest predictor of any 
current drinking among prior nondrinkers (OR: 3.52; 95% CL: 2.19, 5.64). Among 
nondrinkers at the prior visit, no other measured predictors were strongly associated with any 
current drinking in the main analysis; black race was marginally associated with any current 
drinking (OR: 1.37; 95% CL: 1.00, 1.88). In the ancillary analysis, the OR for any illicit drug 
use versus no illicit drug use was 2.07 (95% CL: 1.76, 2.45).  
Table 4.4 presents how the median number of drinks consumed by current drinkers 
differed by time-fixed and time-updated predictors. Over follow-up, current drinkers who 
used marijuana/hash, poppers and cocaine/crack cocaine consumed a median of 8 
drinks/week (IQR: 5-12) whereas non-users consumed a median of 5 drinks/week (IQR: 2-8); 
users of all three categories of drugs consumed alcohol at a level consistent with highest 
quartile of non-users (crude median ratio: 1.60 = 8/5). The multivariable-adjusted ratio of 
median alcohol consumption was 1.14 (95% CL: 1.11, 1.18) comparing users of marijuana, 
poppers and cocaine to non-drug users. Users of marijuana alone, poppers alone or cocaine 
alone consumed a median of 5 drinks per week (IQR: 2-11, 2-11, and 2-13, respectively). 
After multivariable adjustment, the median alcohol consumption ratio of marijuana or 
poppers users compared to non-users was 1.06 (95% CL: 1.03, 1.09); for cocaine users the 
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median ratio was 1.16 (95% CL: 1.09, 1.25). In an ancillary model which considered use of 
any of the three illicit drug categories, the median ratio of alcohol consumed comparing illicit 
drug user to non-users was 1.04 (95% CL: 1.02, 1.07). In the main analysis, current drinkers 
who smoked cigarettes consumed a median of 5 drinks/week (IQR: 2-8) as did non-smokers 
(IQR: 2-12). After multivariable adjustment the median alcohol consumption ratio of 
smokers compared to non-smokers was similar to that of marijuana or poppers users (1.07; 
95% CL: 1.04, 1.09).  
 
Discussion 
This paper presents self-reported alcohol use and consumption patterns over 24 years 
in a cohort of 3,651 urban, predominantly white MSM at risk for HIV infection. We show 
that the proportion of the population that consumed alcohol varied from 82% at baseline to 
64% at its nadir over follow-up. In this cohort, we found that marijuana/hash, poppers and 
cocaine/crack cocaine use predicts higher levels of subsequent alcohol consumption. In 
particular, illicit drug use increased the likelihood of reporting current drinking among prior 
drinkers and prior nondrinkers and was associated with a higher median number of drinks per 
week consumed. 
The proportion of MSM who consume alcohol in our cohort over time is consistent 
with the point prevalence reported in prior cross-sectional and serial cross-sectional studies 
conducted within the same study period. Prior studies that asked HIV seronegative MSM 
participants to recall alcohol consumption from the prior month or longer reported overall 
drinking prevalence between 68% and 97% [3, 170, 174-180]. These rates and ours are 
higher than the 57% of males (age >12 years) of all sexual orientations who reported 
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consuming alcohol as part of the 2006 National Survey on Drug Use and Health [181]. 
However, direct comparisons across these studies should be treated with caution, as the 
sampling methods differed by study: convenience samples of MSM were sometimes 
recruited from venues that serve alcohol [3, 175-177] and predictably differ from national 
samples and surveys of MSM which randomly sampled from the population [170, 174, 178-
180, 182]. 
Our findings expand upon the results of two previous studies examining alcohol 
consumption among MACS participants. In 1991, Penkower et al. reported a heavy drinking 
prevalence of 19% among a sample of 463 members who were HIV-seronegative between 
1984 and 1987 [2]. In 1993, Ostrow et al. examined drinking patterns between 1984 and 
1990 among members of the Chicago MACS/Coping and Change Study cohort, a sub-cohort 
of 384 Chicago MACS participants [79]. Participants reported a near universal history of 
alcohol consumption (90-95%) and a decline in heavy drinking (defined as >59 
drinks/month) from 28% at baseline to 12-15% 5 years later. Our analysis differs from these 
studies of heavy drinking by observing trends over longer time periods and modeling alcohol 
consumption at the level of drinks per week rather than categorizing drinking practices into 
light, moderate or heavy. Our findings confirm that following declines in alcohol 
consumption within the earliest years, the proportion of the cohort who drank ultimately 
stabilized. However, we cannot rule out that men limited alcohol consumption in response to 
the risk reduction messages they received as a result of participating in a long-term study of 
HIV infection, therefore these findings may not be representative of alcohol consumption 
changes in the general population of MSM over this time period. 
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The longitudinal nature of our data allowed us to examine the association between 
potential predictors and alcohol consumption in a way that respected temporality. We report 
that lower education, elevated depression symptoms and black race decreased the likelihood 
of reporting any current drinking among men who reported any drinking at the prior visit. 
Illicit drug was associated with current drinking among prior drinkers and prior nondrinkers, 
and with increased alcohol consumption among current drinkers. Similar to the cross-
sectional findings of Greenwood and colleagues [84], who considered heavy drinking in a 
sample of young MSM (mean age 26 years), age and unprotected receptive anal intercourse 
practices were not predictive of alcohol consumption in our study. However, we did not 
replicate the association they observed with lower education level and we could not examine 
how alcohol consumption differed by profession. Our inability to observe an association 
between education and the number of drinks/week consumed may be due to the relatively 
homogenous high educational attainment of initial MACS participants. MACS participants 
enrolled in the earliest waves of the study are predominantly white, of high socioeconomic 
population status and are likely not representative of the US MSM population overall. We 
anticipate that additional follow-up data from men enrolled into the MACS between 2001 
and 2003 will be able to provide more information on education effects over follow-up, 
because these later recruits are more educationally and racially diverse. Additionally, data on 
other illicit drugs which may be associated with alcohol consumption, such as 
methamphetamine, has been collected consistently for this group. Other large cohorts that 
represent younger, non-urban and minority MSM should be queried to see if the associations 
we report can be replicated in these populations. 
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Examining the association between alcohol consumption and time-updated behaviors 
measured at a previous semiannual visit may obscure the effects of factors whose influence is 
short-lived. For example, cocaine/crack cocaine use may be a strong determinant of alcohol 
consumption over subsequent hours or days, whereas in our analysis the effect of 
cocaine/crack cocaine use in the prior 6-12 months is associated with only a moderate 
increase in alcohol consumption over the subsequent 6-month interval (Table 4.4). A more 
nuanced understanding of the short-term predictors of alcohol consumption requires study 
designs that allow for the collection of study data over shorter intervals or event-level data 
capture.  
Self-reported alcohol consumption over the preceding 6 months is subject to several 
sources of measurement error. First, participants may struggle to recall consumption 
following intoxication or to express the quantity consumed in the same units as the 
questionnaire [58]. Second, retrospectively asking about the quantity and frequency of 
alcohol consumed has been shown to elicit modal rather than median consumption levels 
[183], likely underestimating true self-reported alcohol consumption. Third, social 
desirability bias may lead to the underreporting of stigmatizing behaviors including alcohol 
and other drug use [184]. We believe this latter bias to be minimized in later waves of the 
MACS due to the use of computer-assisted self-administered survey tools [185, 186]. 
Nevertheless, the collection of information on both the study outcome and other sensitive risk 
factors (e.g., illicit drug use) through questionnaires with possible dependent measurement 
errors may bias the observed associations even if misclassification is non-differential [187, 
188]. If participants tend to misreport alcohol consumption in a manner similar to that in 
which they misreport drug use, observed associations may be inflated. 
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Our findings suggest future methodological and health research directions. 
Longitudinal investigations of the association between use of illicit drugs and adverse health 
outcomes among MSM are confounded by alcohol consumption. Future studies should 
consider our finding that prior illicit drug use also affects alcohol consumption. In cases such 
as this, statistical adjustment for alcohol consumption as a time-updated confounder may 
provide biased estimates of the effect of illicit drug use [189]. Therefore, methods that 
account for feedback of confounding covariates on exposures, such as marginal structural 
models [54, 159, 190] are needed to accurately assess the effect of behaviors on downstream 
health events, such as unprotected sexual intercourse that may lead to sexually transmitted 
infection or HIV acquisition.  
Although the median alcohol consumption we observed over follow-up was moderate 
suggesting that most MSM consume alcohol at reasonable levels, the prevalence of heavy 
drinking even among older MSM, should encourage healthcare providers to engage MSM 
patients in discussions of drinking. Barriers to health care and substance abuse treatment 
exist for this vulnerable population [191]. Standards for culturally-competent alcohol 
treatment of MSM are needed that explicitly address the contributions of common 
recreational drugs to the level of alcohol consumption.  
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Tables 
Table 4.1. Characteristics of 3,651 men who have sex with men, 3,651 baseline visits and 
47,261 follow-up visits between1984 and 2007. 
 
  
Baseline  
(n = 3,651)  
Follow-up 
(visits = 47,261)  
Characteristic  No. %, IQR No. %, IQR 
      
Age, median in years  33.0 28.0, 39.0 34.4 28.0, 39.0 
Race/ethnicity:      
White non-Hispanic  3,003 82.3 41,863 88.6 
White Hispanic  200 5.5 1,711 3.6 
Black non-Hispanic  435 11.9 3,618 7.7 
Black Hispanic  13 0.4 69 0.2 
College graduate  2,158 59.1 31,363 66.4  
City:      
Baltimore  1,000 27.4 13,769 29.1 
Chicago  796 21.8 9,913 21.0 
Los Angeles  888 24.3 11,707 24.8 
Pittsburgh  967 26.5 11,872 25.1 
Smoker, currentb   1,528 41.9 13,361 28.3 
Elevated depression symptomsa,b   664 18.2 8,091 17.1 
Illicit drug useb:       
None  851 23.3 22,517 47.6 
Marijuana/hash only  622 17.0 7,077 15.0 
Poppers only  280 7.7 5,900 12.5 
Cocaine/crack only  51 1.4 549 1.2 
Marijuana/hash and poppers  948 26.0 6,008 12.7 
Marijuana/hash and cocaine/crack  231 6.3 2,067 4.4 
Poppers and cocaine/crack  18 0.5 290 0.6 
All  650 17.8  2,853 6.0 
Number of URAI partners b:      
0   1,636 44.81 36,406 77.0 
1  917 25.12 7,801 16.5 
≥ 2  1,098 30.07 3,054 6.5 
Abbreviations: IQR, interquartile range; URAI, unprotected receptive anal intercourse.
aCenter for Epidemiologic Studies Depression Scale (CES-D) >16 
bAt baseline visit, in the prior two years; at follow-up visits, in the prior 6-12 months. 
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Table 4.2. Report of any current drinking among 3,102 men who reported any drinking at the 
prior visit, 35,520 visits between 1984 and 2007. 
 
 
Drinking 
Reported Visits  ORa 95% CL 
 
       
Time-fixed       
Race:     
White 31,068 33,099  1.   
Black 2,114 2,421  0.49 0.37, 0.63  
Education:     
Less than college graduate 10,672 11,564  1.   
College graduate 22,510 23,956  1.30 1.12, 1.51  
     
Time-updated     
Smoking, currentb     
No 23,164 24,825  1.   
Yes 10,018 10,695  1.03 0.89, 1.18  
Elevated depression symptomsb,c     
No 27,995 29,849  1.   
Yes 5,187 5,671  0.75 0.66, 0.86  
Illicit drug usec:     
None 12,852 14,078  1.   
Marijuana/hash only 5,681 6,035  1.67 1.43, 1.95  
Poppers only 4,399 4682  1.39 1.15, 1.68  
Cocaine/crack only 406 448  1.34 0.93, 1.92  
Marijuana/hash and poppers 5,174 5404  2.16 1.77, 2.63  
Marijuana/hash and cocaine/crack 1,812 1,906  2.27 1.75, 2.96  
Poppers and cocaine/crack 240 259  1.27 0.70, 2.32  
All 2,618 2,708  2.90 2.21, 3.80  
Number of URAI partnersc:     
0  24,768 26,637  1.   
1 5,983 6,320  1.18 1.02, 1.36  
≥ 2 2,431 2,563  1.05 0.84, 1.30  
Abbreviations: CL, confidence limits; OR, odds ratio; URAI, unprotected receptive anal 
intercourse. 
aAdjusting for other variables in the table, study site, time since baseline (cubic spline), age 
at baseline (cubic spline) and date of baseline visit (cubic spline). 
bCenter for Epidemiologic Studies Depression Scale (CES-D) >16. 
cIn the prior 6-12 months. 
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Table 4.3. Report of any current drinking among 1,554 men who reported no drinking at the 
prior visit, 11,741 visits between 1984 and 2007. 
 
 
Drinking 
Reported Visits  ORa 95% CL 
       
Time-fixed       
Race:    
White 1,754 10,475  1.  
Black 248 1,266  1.37 1.00, 1.88 
Education:    
Less than college graduate 749 4,334  1.  
College graduate 1,253 7,407  1.05 0.87, 1.26 
    
Time-updated    
Smoking, currentc    
No 1,484 9,075  1.  
Yes 518 2,666  1.03 0.85, 1.25 
Elevated depression symptomsb,c    
No 1,609 9,321  1.  
Yes 393 2,420  0.88 0.75, 1.04 
Illicit drug usec:    
None 1,173 8,439  1.  
Marijuana/hash only 280 1,042  2.27 1.84, 2.80 
Poppers only 234 1,218  1.50 1.15, 1.97 
Cocaine/crack only 35 101  3.52 2.19, 5.64 
Marijuana/hash and poppers 167 604  2.37 1.77, 3.18 
Marijuana/hash and cocaine/crack 57 161  3.30 2.24, 4.88 
Poppers and cocaine/crack 9 31  2.75 1.17, 6.49 
All 47 145  2.93 1.79, 4.78 
Number of URAI partnersc:    
0  1,632 9,769  1.  
1 276 1,481  1.06 0.88, 1.28 
≥ 2 94 491  0.94 0.70, 1.27  
Abbreviations: CL, confidence limits; OR, odds ratio; URAI, unprotected receptive anal 
intercourse. 
aAdjusting for other variables in the table, study site, time since baseline (cubic spline), age 
at baseline (cubic spline) and date of baseline visit (cubic spline). 
bCenter for Epidemiologic Studies Depression Scale (CES-D) >16. 
cIn the prior 6-12 months. 
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Table 4.4. Number of drinks per week consumed by 2,644 current drinkers, 35,184 visits 
between 1984 and 2007. 
 Visits 
Median 
drinks/ 
week  IQR 
Median 
Ratio a 95% CL 
 
       
Time-fixed       
Race:      
White 32,822 5  2, 11  1.  
Black 2,362 5  2, 11  0.98 0.93, 1.02 
Education:      
Less than college graduate 11,421 5  2, 11  1.  
College graduate 23,763 5  2, 11  0.98 0.96, 1.01 
      
Time-updated      
Smoking, current c      
No 24,648 5  2, 8  1.  
Yes 10,536 5  2, 12  1.07 1.04, 1.09 
Elevated depression 
symptomsb,c 
   
  
No 29,604 5  2, 11    
  Yes 5,580 5  2, 11  1.01 0.98, 1.03 
Illicit drug usec:      
None 14,025 5  2, 8  1.  
Marijuana/hash only 5,961 5  2, 11  1.06 1.03, 1.09 
Poppers only 4,633 5  2, 11  1.06 1.03, 1.09 
Cocaine/crack only 441 5  2, 13  1.16 1.09, 1.25 
Marijuana/hash and poppers 5,341 5  2, 12  1.09 1.06, 1.12 
Marijuana/hash and 
cocaine/crack 
1,869 5  2, 12  
1.10 1.06, 1.15 
Poppers and cocaine/crack 249 8  5, 12  1.13 1.03, 1.23 
All 2,665 8  5, 12  1.14 1.11, 1.18 
Number of URAI partnersc:      
0  26,400 5  2, 11  1.  
1 6,259 5  2, 11  0.99 0.98, 1.01 
≥ 2 2,525 5  2, 12  0.99 0.95, 1.02  
Abbreviations: CL, confidence limits; IQR, interquartile range; URAI, unprotected receptive 
anal intercourse. 
aAdjusting for other variables in the table, study site, time since baseline (cubic spline), age 
at baseline (cubic spline), date of baseline visit (cubic spline), and alcohol consumption 
reported at the prior visit (cubic spline). 
bCenter for Epidemiologic Studies Depression Scale (CES-D) >16. 
cIn the prior 6-12 months. 
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Figures 
Figure 4.1. Plots showing the proportion of participants abstaining from alcohol, consuming 
alcohol at moderate levels (0-14 drinks/week) or at heavy levels (>14 drinks/week) by (A) 
participant age and (B) calendar time at baseline and over 47,261 follow-up visits by 3,651 
men between 1984 and 2007.  
A. 
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B. 
  
 
CHAPTER V 
JOINT EFFECTS OF ALCOHOL CONSUMPTION AND HIGH-RISK SEXUAL 
BEHAVIOR ON HIV SEROCONVERSION AMONG MEN WHO HAVE SEX WITH 
MEN 
Introduction 
Men who have sex with men (MSM) remain disproportionately burdened by the HIV 
epidemic. In the United States, an estimated 25,000 to 37,000 MSM were newly infected 
with HIV in 2006 [15], primarily through receptive anal intercourse [12, 24, 192]. Alcohol 
consumption is common among MSM [170] and has been implicated as a risk factor for HIV 
infection [60]. However, existing epidemiologic evidence of an effect of alcohol 
consumption on HIV seroconversion has been mixed [53, 193] and therefore inconclusive for 
supporting population-level alcohol interventions as a strategy for HIV prevention [194]. 
In particular, recent studies using multiple time-updated measures of alcohol 
consumption and adjusting for potential time-updated confounders also provide mixed results 
with one [11] supporting an earlier finding of a harmful association [2] and two not 
supporting a harmful association [3, 9]. However, the standard statistical methods (e.g., 
regression, stratification) used in these recent studies may have failed to provide consistent 
estimates of the hypothesized detrimental effect of alcohol consumption because of 
inadequate control of time-updated confounders [54, 152]. Recent work among injection 
drug users suggests that adjustment for time-updated confounders (e.g., illicit drug use) may 
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block indirect effects of alcohol consumption mediated through such confounders and lead to 
biased effect estimates [195]. 
Here we applied marginal structural models to estimate the association between 
alcohol consumption and HIV seroconversion. Using this approach, we can account for 
measured time-updated confounders affected by prior alcohol consumption. We analyzed 
data from MSM at risk of HIV seroconversion using prospective data from the Multicenter 
AIDS Cohort Study (MACS) collected between 1984 and 2007. Specifically, we examined 
the joint effects of alcohol consumption and unprotected receptive anal intercourse on the 
risk of HIV seroconversion. We hypothesized that both high levels of alcohol consumption 
and unprotected receptive anal intercourse increase the hazard of HIV seroconversion, and 
that this joint effect is greater than multiplicative. 
 
Materials and methods 
Study Sample 
The study sample consisted of a subset of participants enrolled in the MACS, an 
ongoing study of the natural history of HIV infection among MSM in the US metropolitan 
areas of Baltimore, Maryland/Washington DC; Chicago, Illinois; Los Angeles, California; 
and Pittsburgh, Pennsylvania [135]. Enrolled were 6,972 men: 5,622 in 1984-1992 and 1,350 
in 2001. Of these 6,972 men, 4,029 were HIV-seronegative at their baseline visit and were 
therefore eligible for this study. We analyzed data on the 3,725 HIV-seronegative men who 
completed at least one follow-up visit. 
Participants are followed semiannually at study visits that involve a physical 
examination, blood draws, and standardized questionnaires including the Center for 
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Epidemiologic Studies Depression (CES-D) scale [164]. The demographic and risk behavior 
portions of the questionnaire were interviewer administered initially and were converted to 
audio computer-assisted self-interview for newly enrolled participants beginning in October 
2001 and at follow-up visits for all participants in October 2002. Institutional review boards 
approved protocols and written informed consent forms completed by all study participants. 
MACS design details and questionnaires are available at 
http://www.statepi.jhsph.edu/macs/macs.html.  
 
Ascertainment of HIV seroconversion 
Participants were followed from their baseline visit until HIV seroconversion, death, 
loss to follow-up, or administrative censoring. HIV status was determined from blood 
specimens tested by enzyme-linked immunosorbent assay and was confirmed by Western 
blot at each semiannual visit. The midpoint between dates of the last seronegative and the 
first seropositive test was taken as the estimated date of HIV seroconversion; when this date 
was more than one year after the last seronegative test date (n = 33), participants were 
classified as lost to follow-up. Follow-up practices in the MACS cohort have been described 
previously [137]. Briefly, death information was obtained from death certificates, the Social 
Security Death Index, the National Death Index, autopsy records, and other notification 
sources. We censored follow-up for participants who failed to attend study visits for more 
than one year at the minimum of: their date of death (if applicable), one year after their last 
visit, or 1 January 2008 (date of administrative censoring). All remaining seronegative 
participants seen after 1 January 2007 were administratively censored on 1 January 2008. 
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Assessment of alcohol consumption 
The typical number of drinks per week consumed by each participant was calculated 
as the product of participant-reported average number of drinking-days per week and average 
number of drinks per drinking-day (range: 0-84 drinks/week). A drink was defined explicitly 
as one 12-ounce beer, one 4-5-ounce glass of wine, or one mixed drink with 1.5 ounces of 
80-proof hard liquor. The few (<1%) reports of 10 or more drinks per drinking-day were 
classified as 12 drinks. In joint models, we considered three levels of drinking: nondrinkers, 
moderate drinkers (1-14 drinks/week), and heavy drinkers (>14 drinks/week) based on 
reports averaged over the prior two visits (approximately one year). This exposure window 
was chosen to maximize stability of the alcohol measurement. We considered the impact of 
this choice of exposure window on our results by considering a range of empirical induction 
periods (≥2 years prior) shown in Appendix 1.5.1. Trends were generally insensitive to the 
exposure window chosen although, as expected, the magnitude of the observed effect 
decreased as length of the exposure window increased. 
 
Assessment of sexual risk behavior 
The number of unprotected receptive anal intercourse partners (hereafter, partners) a 
participant reported was previously identified as a strong predictor of HIV seroconversion in 
the MACS [24, 192] and other cohorts [12]; we therefore consider this exposure a marker of 
overall sexual risk behavior. Participants self-report the number of partners they have had at 
each semiannual visit. The few (<1%) reports of more than six partners since the previous 
visit were reset to the median of those with more than six partners (10 partners). In joint 
models, we considered two levels of receptive anal intercourse: one or fewer partners and 
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multiple partners. Similar to alcohol measures, we averaged the number of partners over the 
previous two visits. The overall joint distribution of alcohol consumption and partner number 
is presented in Appendix 2.5.1 and by time in Appendix 1.5.2. 
 
Assessment of covariates 
Based on previously identified determinants of alcohol consumption [140, 196] and 
HIV risk factors [9], we considered several time-fixed and time-updated covariates as 
confounders. The following variables were assessed at baseline: participant’s race and 
ethnicity (white non-Hispanic, white Hispanic, or black), age, enrollment city, and education 
(college graduate or not). Data on time-updated confounders were recorded at each 
semiannual visit and included depressive symptoms indicated by a CES-D score >16; self-
report of either gonorrhea or Chlamydial infection; cigarette smoking (current or not); and 
use of any of the following illicit drugs: cocaine, crack cocaine, marijuana/hash, or nitrite 
inhalants (i.e., poppers). Injection drug use was uncommon (<1%) as was methamphetamine 
use (4%), which furthermore was not captured consistently over follow-up. Just 7% of the 
cohort reported use of any other drugs, including heroin. We therefore considered these three 
most common illicit drugs categories as confounders. 
Baseline data on smoking, CES-D score and number of partners were missing for 6%, 
6%, and 7% of participants, respectively. Data on all other variables were missing for <2% of 
participants. For values missing at baseline, we imputed the mode. For missing values over 
follow-up, the value from the previous visit was carried forward (smoking, 6%; CES-D 
score, 8%; number of partners, 9%; all others, <4%).  
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Statistical Analysis 
 We used a marginal structural Cox proportional hazards model to estimate the joint 
effects of alcohol consumption and partner number on HIV seroconversion [156]. The joint 
marginal structural model provides asymptotically consistent estimates of contrasts in 
potential outcomes under the assumptions of consistency, exchangeability, positivity, and 
correct model specification for each exposure and censoring.  
Inverse probability of exposure weights for all models were constructed to account 
for confounding as the product of the inverse probability of each participant’s observed 
alcohol consumption and the inverse probability of his observed number of partners 
estimated as a function of his history of measured time-updated predictors. Exposure weights 
were calculated from a pair of cumulative pooled logistic regression models [155]: each 
accounted for the following time-updated confounders, lagged one visit: elevated depression 
symptoms, smoking status, use of illicit drugs and self-reported sexually transmitted 
infection. In addition, the weight model for partner number also included concurrent alcohol 
consumption. These weights were stabilized to improve precision by alcohol consumption 
history (product terms between alcohol consumption at 6, 12, and 18 months prior and 
restricted cubic splines with knots at the 5th, 27.5th, 50th, 72.5th and 95th percentiles for 
consumption at those time points), partner history (product terms between partner number at 
6, 12 and 18 months prior), and time-fixed covariates measured at baseline [148]. To reduce 
the potential impact of informative censoring, inverse probability of dropout and death 
weights were calculated similarly using separate pooled logistic models and those weights 
were combined with the exposure weights by multiplication. The final weights had a mean of 
1.00 (standard deviation, 0.26) with a range of 0.10-7.56 (Appendix 2.5.2). 
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This final joint marginal structural Cox proportional hazards model for HIV 
seroconversion included as regressors alcohol consumption averaged over the prior year 
(categorized as none, moderate, or heavy), number of receptive anal intercourse partners 
averaged over the prior year (categorized as ≤ 1 or >1), and their product terms. All models 
also included a restricted cubic spline representing time since baseline, with knots at the 
percentiles described above, as well as baseline variables race, ethnicity, college graduation, 
study site and age (modeled as a restricted cubic spline; described above). Cumulative 
incidence of HIV seroconversion curves are presented in the weighted population [197]. 
Effects were quantified using hazard ratios (HRs), and precision was assessed through 95% 
confidence limits (CL) based on robust variances. Departure from additivity was assessed 
using the relative excess risk due to interaction (RERI) [160]. We evaluated the contribution 
of the product term using a joint robust Wald 2 test. No evidence of departure from 
proportional hazards for the joint effect was observed in models that included exposure by 
time (P = 0.86) or exposure by log-time (P = 0.70) product terms.  
Alongside our weighted results, we present observed counts of HIV seroconversions 
and corresponding incidence rates calculated as number of HIV seroconversions divided by 
the number of person years of observation. We also present results from standard analyses, 
which adjust for time-updated confounders by including lagged values of time-updated 
covariates in a standard Cox model [162]. All analyses were conducted with SAS version 9.2 
(SAS Institute, Inc., Cary, North Carolina). 
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Results 
Between 1984 and 2007, 3,725 men were followed for a median of 10.5 years 
(interquartile range (IQR): 4.7-11.7), during which 529 HIV seroconversions were observed. 
Eighty-three (2%) participants died during follow-up, 311 (8%) were lost to follow-up, and 
2,802 (75%) were administratively censored.  
Participants were mostly white non-Hispanic (82%) and college educated (59%) 
(Table 5.1). At baseline, members of this sexually active population reported a median of 1 
(IQR: 0-2) partner in the prior two years. Illicit drug use was common (77%), as was 
smoking (51%) and most participants consumed alcohol (9% nondrinkers) but at a generally 
moderate level: median 8 drinks/week (IQR: 2-16). Over follow-up, HIV risk behaviors were 
less prevalent: 78% of participants reported no partners; illicit drug use was reported by 48% 
of participants, and median alcohol consumption was 4 drinks/week (IQR: 2-12), each 
measured in the prior six months (Appendix 1.5.3).  
Reports of heavy drinking were most common from white non-Hispanics (92%), 
illicit drug users (73%), and men reporting multiple partners (13%) (Appendix 1.5.4). Men 
reporting 0-1 or >1 partner on average over the prior year experienced crude HIV incidence 
rates of 9 (95% CL: 8, 10) and 76 (95% CL: 66, 86) cases per 1,000 person-years, 
respectively. Figure 5.1A depicts this cumulative incidence for these two groups in the 
weighted population. For nondrinkers, moderate drinkers and heavy drinkers over the prior 
year the crude incidence of HIV seroconversion were 10 (95% CL: 7, 13), 13 (95% CL: 12, 
15), and 26 (95% CL: 22, 31) cases per 1,000 person-years, respectively (Table 5.2). Heavy 
drinkers were most likely to HIV seroconvert over follow-up in the weighted population ( 
Wald trend test P = 0.0057) (Figure 5.1B). 
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Table 5.2 presents the effects of alcohol consumption on HIV seroconversion from 
models that average over partner effects. In unadjusted, adjusted, and weighted models, the 
hazard for moderate drinkers was similar to that for nondrinkers, whereas the hazard for 
heavy drinkers was elevated. Compared to the unadjusted HR for heavy drinkers of 1.52 
(95% CL: 1.07, 2.16), adjustment for age, race, ethnicity, study site, depression symptoms, 
college graduation, smoking, illicit drug use, number of partners, and sexually transmitted 
infection using standard methods produced an attenuated HR of 1.19 (95% CL: 0.83, 1.70). 
After accounting for the same variables using marginal structural models, the hazard of HIV 
seroconversion for heavy drinkers in the past year was 1.61 (95% CL: 1.12, 2.29) times that 
of nondrinkers. 
Table 5.4 presents the joint effects of alcohol consumption and partners in the prior 
year from models that include a product term. We represent these joint effects in two ways: 
(1) by examining the effect of alcohol consumption within strata of partners; and (2) by 
presenting HRs relative to a common referent: nondrinkers without multiple partners. In the 
weighted model, the association between heavy drinking and HIV seroconversion appeared 
stronger among men with multiple partners (HR = 1.96; 95% CL: 1.03, 3.72) versus without 
(HR = 1.37; 95% CL: 0.88, 2.16), although this difference was imprecise (P = 0.42) (Table 
5.4). The observed HR for moderate drinkers with multiple partners compared to nondrinkers 
without multiple partners (HR = 4.48) was similar to those expected under a multiplicative 
model (HRexpected = 4.04). The observed HR for heavy drinkers with multiple partners 
compared to nondrinkers without multiple partners was larger than expected under a 
multiplicative model: HR = 7.40 and HRexpected = 5.18, although this departure was imprecise 
(Table 5.4). With respect to interaction on the additive scale, the RERI suggests departure 
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from additivity for heavy drinkers with multiple partners (RERI = 3.25; 95% CL: 0.32, 6.17) 
but not moderate drinkers with multiple partners (RERI = 0.63; 95% CL: -1.81, 3.07).  
Again, compared to results from the standard Cox model, results from the weighted 
model suggested a stronger effect. For example, when heavy drinkers with multiple partners 
were compared to nondrinkers without multiple partners, the HR from the marginal structural 
model was 7.40 (95% CL: 4.74, 11.54) and the analogous HR from the standard adjusted 
model was 4.97 (95% CL: 3.18, 7.77) (Table 5.4). Similar to the weighted analysis, no 
statistically significant evidence was found for greater-than-multiplicative interaction in the 
standard analysis (P = 0.28) (Table 5.4). 
 
Discussion 
We reported the effect of alcohol consumption and risky sexual behavior on HIV 
seroconversion in prospective data on 3,725 MSM followed in 1984-2007. Heavy alcohol 
consumption was associated with 1.61 times the hazard of HIV seroconversion compared to 
no consumption. We furthermore presented results from models that use traditional 
adjustment approaches alongside results from weighted models showing that traditional 
approaches appeared to produce attenuated estimates. Without results from the weighted 
models, we might have erroneously concluded that there was no independent association 
between alcohol consumption and HIV seroconversion. 
The unadjusted HR of 1.52 we reported for heavy alcohol consumption versus 
nondrinking is similar to unadjusted HRs reported in previous studies of MSM populations 
[1-3, 9, 11, 12]. We reported an attenuated HR of 1.19 when adjusted for time-updated 
confounders using traditional adjustment. This attenuation mirrors that reported by the San 
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Francisco Men’s Health Study [3] and in an earlier report of MACS data [9]. The latter study 
reported an unadjusted HR of 2.05 (95% CL: 1.53, 2.74) for heavy versus less-than-heavy 
drinking but an HR of 1.13 (95% CL: 0.81, 1.56) after adjustment for time-updated 
confounders. A statistically significant adjusted association between heavy alcohol 
consumption and HIV seroconversion persisted in only the EXPLORE cohort (HR= 1.97; 
95% CL: 1.32, 2.96) [11]. Our findings and the majority of previous studies suggest that 
standard adjustment removes part of the indirect effect of alcohol consumption mediated 
through other time-updated HIV risk factors for which authors have previously adjusted (e.g., 
illicit drug use).  
Changes in behaviors and expectancy that accompany alcohol consumption may be 
responsible for increased sexual risk behaviors and for subsequent HIV seroconversion 
observed among heavy drinkers [91, 101]. Alcohol consumption is associated with higher 
numbers of sexual partners, higher numbers of unprotected anal sex acts, and condom failure 
[84, 86]. Acute alcohol consumption has also been linked to suppression of both the innate 
and adaptive immune response and increased susceptibility to numerous infections, including 
HIV [101, 115, 198, 199].  
A limitation of the present data is collection of alcohol consumption measures that 
require recall over a 6-month period. As researchers have stated previously, global measures 
of alcohol consumption do not allow investigation of specific contextual modifiers of the 
relationships between alcohol consumption and sexual risk behaviors such as partner type 
and partner’s alcohol consumption [47, 60, 200]. These contextual factors in turn may 
explain why we did not see a dramatic departure from multiplicative combination between 
the effects of alcohol consumption and sexual risk behavior. For example, researchers have 
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found that MSM are more likely to use condoms with casual partners while drinking but less 
likely to use condoms with steady partners in the same setting [72, 87, 88].  
Self-reported alcohol consumption may also be an inadequate proxy for alcohol-
induced responses. The behavioral and physiologic effects of alcohol are person-specific, 
dependent on genetic background, body mass composition and diet. Future research applying 
biomarkers of alcohol consumption to evaluate the reliability or accuracy of self-report data 
is needed in studies of sexual health. 
As with any analysis, the validity of our inferences is limited by the degree to which 
we met our assumptions. First, we assumed no unmeasured confounding and no informative 
censoring due to unmeasured factors. However, there are likely unmeasured behavioral 
factors confounding the observed association. Moreover, we acknowledge that measurement 
of the confounders we included is imperfect (e.g., self-reported as opposed to directly 
assessed sexually transmitted infections). Second, we assumed that heavy drinkers who 
seroconverted during the study period are representative of those who seroconverted prior to 
study entry. Men who seroconverted prior to study entry may have engaged in more 
concomitant high-risk behaviors than those whose seroconversion was observed, leading us 
to observe a weaker association between alcohol consumption and HIV seroconversion. 
Third, we assumed that mode of exposure is irrelevant to the observed outcome [149]. 
However, the behavioral mechanisms described above suggest that ignoring type of alcohol 
consumed and timing of its consumption with respect to HIV exposure may not be 
reasonable and may limit our ability to prescribe generalizable interventions based on our 
findings. Nevertheless, the demonstrable effect of alcohol consumption, measured broadly, is 
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valuable in that it supports research to identify the particular means of exposure relevant for 
interventions. 
 This study has several important strengths. First, it used information from a large 
prospective cohort of sexually active MSM followed for over 2 decades. Second, a large 
number of HIV seroconversions were observed, including a sizable portion among men 
previously reporting heavy drinking. Finally, using state-of-the-art quantitative methods, this 
study more fully captures the direct and indirect effects of alcohol consumption on HIV 
seroconversion-- specifically, both the direct effect of alcohol on HIV susceptibility and the 
indirect effects mediated through HIV risk behaviors, such as illicit drug use that are also 
affected by prior alcohol consumption.  
The potential for linking alcohol interventions with HIV prevention activities was 
described more than a decade ago [201], and randomized interventions that explicitly address 
alcohol’s contribution to HIV have been tested in Africa [131, 132, 202]. However, such 
interventions have lagged behind for US adult MSM [200]. We have reported an effect of 
alcohol consumption on HIV seroconversion among MSM of similar magnitude to illicit 
drugs such as methamphetamine, cocaine, and ecstasy [9]. Under the above-stated 
assumptions, our results support the conclusion that 16% of HIV seroconversions among 
heavy drinkers could be prevented if half of these drinkers reduced their drinking to moderate 
levels; 21% could be prevented if two-thirds reduced their drinking to moderate levels [163]. 
If replicated, our findings renew the call for population-level HIV interventions among US 
MSM that explicitly address heavy alcohol consumption. 
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Tables 
Table 5.1. Enrollment characteristics of 529 Multicenter AIDS Cohort Study HIV 
seroconverters and 3,196 HIV-seronegative participants 
  
Seroconverters 
(n = 529)  
Seronegative 
Participants 
(n = 3,196)  
Total 
(n = 3,725) 
Characteristic  n %  n %  n % 
          
Median age at baseline in 
years (IQR)  30.8 (26.3, 36.4)  33.7 (28.4, 40.0)  33.4 (28.0, 39.6) 
Race/ethnicity:     
White non-Hispanic  440 83.2 2,623 82.1  3,063 82.2
White Hispanic  38 7.2 166 5.2  204 5.5
Black  51 9.6 407 12.7  458 12.3
College graduate  274 51.8 1921 60.1  2195 58.9
US city:     
Baltimore, Maryland  134 25.3 882 27.6  1,016 27.3
Chicago, Illinois  123 23.3 687 21.5  810 21.7
Los Angeles, California  118 22.3 874 27.3  992 26.6
Pittsburgh, 
Pennsylvania  154 29.1 753 23.6  
907 
24.3
Median alcohol 
consumptiona in 
drinks/week (IQR)  8 (4, 16)  8 (2, 14)  8 (2, 16) 
0   29 5.5 286 8.9  315 8.5
1-14   327 61.8 2,119 66.3  2,446 65.7
>14   173 32.7 791 24.7  964 25.9
Smokera  292 55.2 1591 49.8  1883 50.6
Depressive symptomsa,b   88 16.6 588 18.4  676 18.1
Illicit drug usea,c  466 88.1 2,387 74.7  2,853 76.6
Number of URAI 
partnersa    
 
0 -1  225 42.5  2,380 74.5   2,605 69.9
>1  304 57.5  816 25.5   1,120 30.1
Sexually transmitted 
infectionsa,d  63 11.9 215 6.7  278 7.5
Abbreviations: IQR, interquartile range; URAI, unprotected receptive anal intercourse. 
a Prior two years. 
b Center for Epidemiologic Studies Depressions (CES-D) >16. 
c Marijuana/hash, cocaine/crack cocaine, or poppers. 
d Chlamydia or gonorrhea.
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Table 5.2. Effect of alcohol consumptiona on HIV seroconversion among 3,725 men in the Multicenter AIDS Cohort Study between 
1984 and 2007. 
   Unadjusted  Adjustedb Weightedc 
 Number of  
Seroconversions PY HR  95% CL 
 
HR  95% CL HR  95% CL
          
Nondrinker 40 4,062.98 1.   1. 1.  
Moderate Drinker  340 26,084.75 1.11 0.80, 1.54  0.91 0.65, 1.27 1.10 0.78, 1.54 
Heavy Drinker 149 5,722.04 1.52 1.07, 2.16  1.19 0.83, 1.70 1.61 1.12, 2.29 
 
Abbreviations: CL, confidence limits; HR, hazard ratio; PY, person-years. 
a Alcohol consumption in the prior year: nondrinker (0 drinks/week), moderate drinker (0-14 drinks/week), heavy drinker (>14 
drinks/week). 
b Cox proportional hazards model adjusted for baseline (age (spline), race, ethnicity, education) covariates and time-updated (illicit 
drug use, cigarette smoking, depression, sexually transmitted infection, and multiple unprotected receptive anal intercourse partners) 
covariates lagged one visit. 
c Cox proportional hazards model weighted to account for confounding and selection bias by time-updated covariates lagged one visit 
and adjusted for baseline covariates
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Table 5.3. Effects of alcohol consumptiona and risky sexual behavior in the prior year on 
HIV seroconversion among 3,725 men in the Multicenter AIDS Cohort Study between 1984 
and 2007. 
 ≤ 1 URAI Partner >1 URAI Partner  
 
HRb 95% CL HRb 95% CL HRc 95% CL 
P- 
valued 
   
Unadjusted   0.50
Nondrinker 1. 4.12 2.04, 8.32 1. 
Moderate drinker 1.07 0.73, 1.58 5.04 3.33, 7.63 1.22 0.66, 2.27
Heavy drinker 1.31 0.84, 2.05 7.62 4.97, 11.70 1.85 0.99, 3.46
   
Adjustede   0.28
Nondrinker 1. 3.21 1.57, 6.60 1. 
Moderate drinker  0.86 0.58, 1.28 3.31 2.15, 5.10 1.03 0.55, 1.94
Heavy drinker 0.97 0.61, 1.52 4.97 3.18, 7.77 1.55 0.81, 2.94
   
Weightedf   0.42
Nondrinker 1. 3.78 1.82, 7.82 1. 
Moderate drinker  1.07 0.72, 1.59 4.48 2.91, 6.88 1.19 0.63, 2.24 
Heavy drinker 1.37 0.88, 2.16 7.40 4.74, 11.54 1.96 1.03, 3.72 
 
Abbreviations: CL, confidence limits; HR, hazard ratio; URAI, unprotected receptive anal 
intercourse. 
a Alcohol consumption in the prior year: nondrinker (0 drinks/week), moderate drinker (0-14 
drinks/week), heavy drinker (>14 drinks/week). 
b Nondrinkers with ≤ 1 URAI partner as referent. 
c Nondrinkers with >1 URAI partner as referent. 
d Joint robust Wald 2 test. 
e Adjusted for baseline (age (spline), race, ethnicity, education) covariates and time-updated 
(illicit drug use, cigarette smoking, depression, sexually transmitted infection) covariates 
lagged one visit. 
f Weighted to account for time-updated covariates lagged one visit and adjusted for baseline 
covariates. 
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Figures 
Figure 5.1. Cumulative incidence of HIV seroconversion between 1984 and 2007 among 
3,725 men who have sex with men, stratified by (A) the number of sexual partners with 
whom the participant was the receptive anal intercourse partner and (B) alcohol 
consumption, in the prior year. 
A. 
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B. 
 
 
 
CHAPTER VI 
CONCLUSIONS 
Summary 
In this dissertation, we have implemented methods to obtain estimates of the effect of 
alcohol consumption on HIV seroconversion among MSM. Alcohol consumption patterns in 
the MACS were detailed, showing that the proportion of the population that consumed 
alcohol varied from 82% at enrollment to 64% at its nadir over follow-up. Illicit drug use 
predicted higher levels of subsequent alcohol consumption. We applied an understanding of 
the time-varying predictors of alcohol consumption to an inverse probability of exposure 
weighted marginal structural model to estimate the effect of alcohol consumption on HIV 
seroconversion and found that heavy alcohol consumption (>14 drinks/week) was associated 
with 1.61 (95% CL: 1.12, 2.29) times the hazard of HIV seroconversion compared to no 
consumption after accounting for measured confounders. This effect is similar to the pooled 
relative risk of 1.77 (95% CL l: 1.43, 2.19) observed in a recent meta-analysis of alcohol 
consumption and HIV seroconversion that did not account for time-varying confounding 
[193].  
 The MACS is the largest and longest-running prospective cohort of adult MSM in the 
US. We observed a large number of HIV seroconversions including a sizable portion among 
men previously reporting heavy drinking. A strength of this study that it is the first work to 
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present longitudinal predictors of alcohol consumption among adult MSM over multiple 
visits. We improve upon previous methodologies by intentionally lagging time-updated 
predictor variables and alcohol outcomes. Our examination of alcohol consumption, 
unprotected receptive anal intercourse and HIV seroconversion is also novel in that it applied 
state-of-the-art quantitative methods that explicitly address the potential interaction between 
alcohol consumption and high risk sexual behavior. 
 
Limitations 
 The MACS was not intended to be a nationally representative sample of MSM by 
design, nor was it fully representative of MSM in the metropolitan areas from which 
participants were recruited [135]. Compared to the general population, men in the MACS are 
disproportionately well-educated, financially secure and of white non-Hispanic. We have 
speculated that younger, non-urban, and economically disadvantaged MSM may not have 
decreased risk behaviors as a result of the HIV epidemic in the same ways MACS enrollees 
in the mid-1980s appear to have done. While white men continue to make up the majority of 
new HIV infections among MSM in the US, they are rapidly being outnumbered by men of 
color [16]. Lack of representation in the MACS may have implications for the results of our 
second aim if the circumstances of alcohol consumption or the susceptibility to the alcohol-
induced effects on HIV seroconversion are different for members of underrepresented 
subgroups. Additionally, we can only generalize with caution to populations with vastly 
different alcohol consumption profiles or where the underlying distribution of unmeasured 
confounders differs. Therefore ongoing study of alcohol consumption by minority and 
younger MSM is needed to inform interventions for these groups; cohorts that represent 
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younger, non-urban and minority MSM should be queried to see if the associations we report 
can be replicated in these populations. 
 As in prior studies, the alcohol consumption reported by study participants was not 
verified. The potential impact of this measurement error has been discussed in the preceding 
chapters. More work is needed in developing and applying biomarkers of alcohol 
consumption useful for research as opposed to clinical purposes. We viewed with optimism 
the recent application of carbohydrate-deficient transferrin to validate sustained heavy 
drinking among HIV seroconverters in Uganda [203] and anticipate more HIV cohorts will 
include alcohol biomarker as part of routine testing.  
No examination of how participant-specific genetic, neurocognitive, and metabolic 
factors may influence alcohol expectancies, consumption or subsequent risk behaviors could 
be addressed in the current work. These will certainly have implication for future alcohol 
interventions and must be considered. 
  
Implications 
Improving the health, safety, and well-being of lesbian, gay, bisexual, and 
transgender individuals is among the US government’s health goals of the current decade 
[204]. Priority areas for MSM include curbing HIV transmission and addressing disparities in 
alcohol consumption in this subpopulation, both points addressed by this dissertation. Our 
findings support alcohol intervention for MSM who use illicit substances and, along with 
previous findings, suggest that interventions which explicitly address alcohol consumption 
should be developed as HIV primary prevention methods.  
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Challenges exist to moving alcohol interventions forward. Alcohol consumption is 
socially accepted and central to the identities of many MSM. With the exceptions of driving 
penalties and alcohol taxes, top-down population-level approaches to reducing alcohol 
consumption are also limited. Nevertheless, the magnitude of the reported findings support 
primary prevention approaches focused at reducing heavy alcohol consumption of the same 
scale as those directed against illicit drugs. Approaches to reducing alcohol consumptions 
should include developing, piloting, and promoting culturally-competent alcohol treatment 
programs for heavy drinkers, particularly those with comorbid substance abuse, who require 
medical support. Furthermore, improvements to existing community-based alcohol 
interventions should also be considered, so that they incorporate messages that encourage 
MSM to moderate their drinking.  
 
Future studies 
When we applied marginal structural models to examine the independent association 
between alcohol consumption and HIV seroconversion, we found an effect that was not 
apparent under standard adjustment. Therefore such analysis should be replicated in other 
HIV risk groups including longitudinal cohorts in sub-Saharan Africa, where alcohol 
interventions are already underway and HIV is more prevalent. Our results also suggest that 
other associations for which there have been limited or contradictory results so far and where 
time-varying confounders affected by prior exposure are a concern should be re-examined 
using this methodology. Future studies should reconsider the associations between alcohol 
consumption and unprotected receptive anal intercourse and non-HIV sexually transmitted 
infections [45, 49].  
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Next steps for characterizing the effect of alcohol consumption on HIV 
seroconversion include effect decomposition approaches using marginal structural models 
[205]. Under specific conditions, the effect of alcohol consumption mediated through 
identifiable pathways can be estimated. These approaches may support the existence of 
immune-modulated pathways suggested by laboratory studies. 
Finally, more research is needed on the effect of alcohol on the natural history of HIV 
infection following seroconversion. In particular, research on the extent to which alcohol 
consumption influences adherence to antiretroviral medication and secondary prevention 
(i.e., long-term immunologic and virologic outcomes). Recent findings that early treatment of 
HIV provides protection to HIV seronegative partners [206], suggests that research into 
factors that impede early treatment-seeking and long-term adherence are needed.  
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APPENDICES 
 
Appendix 1. Additional tables 
Appendix 1.5.1. Comparison of empirical induction periods. 
Length of Exposure 
Window, Years  1  1.5  2 
 
  HR 95% CL HR 95% CL HR 95% CL
           
Overall           
Nondrinker  1. 1. 1.  
Moderate drinker   1.10 0.78, 1.54  1.06 0.75, 1.49  1.02 0.72, 1.44 
Heavy drinker  1.61 1.12, 2.29  1.56 1.08, 2.23  1.44 1.00, 2.08 
            
>1 URAI partner            
Nondrinker   1.    1.    1.  
   Moderate drinker   1.19 0.63, 2.24  1.23 0.63, 2.39  1.12 0.60, 2.10 
Heavy drinker  1.96 1.03, 3.72  1.90 0.97, 3.70  1.67 0.88, 3.16 
            
0-1 URAI partner            
Nondrinker   1.    1.    1.  
Moderate drinker   1.07 0.72, 1.59  0.99 0.66, 1.49  0.97 0.64, 1.49 
Heavy drinker  1.37 0.88, 2.16  1.39 0.89, 2.18  1.30 0.82, 2.07 
            
Abbreviations: CL, confidence limits; HR, hazard ratio; URAI, unprotected receptive anal 
intercourse. 
 
  
 87 
 
Appendix 1.5.2. Distribution of alcohol consumption and risky sexual behavior by time-on-
study over 57,651 follow-up visits by 3,725 men between 1984 and 2007.  
>1 URAI Partner, %  0-1 URAI Partner, % 
Year n None Moderate Heavy  None Moderate Heavy 
0 3,725 7.95 15.47 1.97  51.66 7.04 15.92 
1 3,210 2.22 5.18 0.81  65.69 10.74 15.38 
2 2,934 1.13 2.7 0.23  69.82 11.62 14.49 
3 2,725 0.77 1.84 0.21  70.35 12.95 13.88 
4 2,530 0.49 1.43 0.31  70.17 12.93 14.67 
5 2,177 0.51 0.99 0.3  69.79 13.59 14.83 
6 2,032 0.72 1.35 0.24  68.8 15.84 13.06 
7 1,965 0.33 1.14 0.28  69.24 15.06 13.95 
8 1,903 0.35 1.03 0.15  68.03 16.24 14.2 
9 1,836 0.3 0.7 0.33  70.56 15.51 12.61 
10 2,235 0.36 1.16 0.04  68.05 17.41 12.98 
11 1,494 0.62 1.33 0  66.67 18.66 12.72 
12 624 0.89 1.58 0  69.33 16.96 11.24 
13 417 0.53 3.48 0.67  65.37 17.38 12.57 
14 390 0.14 3.01 1  68.05 15.76 12.03 
15 362 0.3 3.35 0.91  67.99 16.16 11.28 
16 367 0.45 3.33 0.91  64.75 18.31 12.25 
17 439 0 4.76 0.54  68.3 15.92 10.48 
18 418 0.82 4.12 1.23  64.06 15.23 14.54 
19 378 0.94 3.94 1.57  63.94 16.38 13.23 
20 320 0.9 4.32 1.08  67.63 16.37 9.71 
21 260 0.64 5.75 0.64  64.89 18.51 9.57 
22 200 1.75 5.26 1.17  65.79 13.74 12.28 
23 37 0 8.11 0  64.87 13.51 13.51 
Abbreviation: URAI, unprotected receptive anal intercourse.  
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Appendix 1.5.3. Characteristics of 529 Multicenter AIDS Cohort Study HIV seroconverters and 3,196 HIV-seronegative participants 
studied over 57,651 follow-up visits. 
 
  
Seroconverter 
(3,192 visits)  
Seronegative  
(54,459 visits)   
Total 
(57,651 visits) 
Characteristic:  n %  n %  n % 
          
Median age at baseline, in 
years (IQR)  30.2 (26.3, 36.4)  33.8 (28.8, 39.7)  33.6 (28.7, 39.5) 
Race/ethnicity   
White non-Hispanic  2,715 85.1 48,304 88.7 51,019 88.5
White Hispanic  249 7.8 4,179 7.5 4,428 7.7
Black  228 7.1 1,976 3.6 2,204 3.8
College graduate  1,804 56.5 35,698 65.6 37,502 65.1
US City   
Baltimore, Maryland  750 23.5 14,934 27.4 15,684 27.2
Chicago, Illinois  708 22.2 10,976 20.2 11,684 20.3
Los Angeles, California  1,052 33.0 14,702 27.0 15,754 27.3
Pittsburgh, Pennsylvania  682 21.4 13,847 25.4 14,529 25.2
Median alcohol 
consumptiona, in 
drinks/week  8 (2, 14)  4 (2, 12)  4 (2, 12) 
0   352 11.0 7,638 14.0 7,990 13.9
1-14   2,144 67.2 38,402 70.5 40,546 70.3
>14   696 21.8 8,419 15.5 9,115 15.8
Smoker, ever  1,845 57.8 26,466 48.6 28,311 49.1
Depressive symptomsa   397 12.4 9,393 17.2 9,790 17.0
Illicit drug usea,c  1,990 62.3 25,714 47.2 27,704 48.1
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Seroconverter 
(3,192 visits)  
Seronegative  
(54,459 visits)   
Total 
(57,651 visits) 
Characteristic:  n %  n %  n % 
Number of URAI partnersa:   
0   1,978 62.0 42,761 78.5 44,739 77.6
1  640 20.1 8,939 16.4 9,579 16.6
>1  574 18.0 2,759 5.1 3,333 5.8
Sexually transmitted 
infectionsa,d  201 6.3 1,533 2.8 1,733 3.0
Abbreviations: IQR, interquartile range; URAI, unprotected receptive anal intercourse. 
a Prior six months. 
b Center for Epidemiologic Studies Depression scale (CES-D) >16. 
c Marijuana/hash, cocaine/crack cocaine or poppers. 
d Chlamydia or gonorrhea. 
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Appendix 1.5.4. Characteristics of Multicenter AIDS Cohort Study participants stratified by alcohol consumption reported over 
57,651 follow-up visits. 
  
0 drinks/week (7,990 
visits)  
1-14 drinks/week 
(40,546 visits)  
>14 drinks/week 
(9,115 visits) 
Characteristic:  n %  n %  n % 
          
Median age at baseline, in years (IQR)  35.6 (30.1, 40.8)  33.4 (28.4, 39.1)  33.9 (28.5, 39.7) 
Race/ethnicity:   
White non-Hispanic  6,783 84.9  35,921 88.6  8,315 91.2 
White Hispanic  324 4.1  1,647 4.1  233 2.6 
Black  883 11.1  2,978 7.3  567 6.2 
College graduate  4,662 58.3  27,407 67.6  5,433 59.6 
Smoker, ever  4,751 59.5  17,931 44.2  5,629 61.8 
Depressive symptomsa   1,863 23.3  6,966 17.2  1,637 18.0 
Illicit drug usea,c  2,094 26.2  21,817 53.8  6,646 72.9 
Number of URAI partnersa:          
0   6,552 82.0  29,932 73.8  6,202 68.0 
1  1,012 12.7  7,733 19.1  1,767 19.4 
>1  426 5.3  2,881 7.1  1,146 12.6 
Sexually transmitted infectionsa,d  203 2.5  1,216 3.0  315 3.5 
Abbreviations: IQR, interquartile range; URAI, unprotected receptive anal intercourse. 
a Prior six months 
b Center for Epidemiologic Studies Depression Scale (CES-D) >16 
c Marijuana/hash, cocaine/crack cocaine or poppers 
d Chlamydia or Gonorrhea 
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Appendix 2. Additional figures 
Appendix 2.4.1. Plot of alcohol consumption by time-on-study at baseline and over 47,261 
follow-up visits by 3,651 men between 1984 and 2007.  
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Appendix 2.4.2. Box plots of alcohol consumption by illicit drug use (marijuana/hash (M), 
poppers (P) or cocaine/crack cocaine (C)) for 3,651 men seen at baseline and at 47,261 
follow-up visits (percentages are of visits) between 1984 and 2007. 
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Appendix 2.5.1. Scatterplot of alcohol consumption (drinks/week) by number of unprotected 
receptive anal intercourse partners reported over 57,651 follow-up visits, between 1984 and 
2007. 
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Appendix 2.5.2. Distribution of stabilized weights (mean, 1.00; standard deviation, 0.26) 
over time and as box plots by study visit year. 
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